{"chunk_type":"transcript_chunk","text":"# LM_Neuro 3\n**Overview: High-Yield Peripheral Neurology & MND**\n| **Disease Entity** | **Key Mechanism/Presentation** | **Gold Standard Dx / Key Lab** | **Treatment / Next Step** |\n| --- | --- | --- | --- |\n| **UMN Lesion** | Spasticity, Hyperreflexia, Babinski (+) | Clinical Exam (Pronator Drift) | MRI Brain/Spine |\n| **LMN Lesion** | Flaccidity, Atrophy, Fasciculations | Clinical Exam | EMG/NCS |\n| **ALS** | **Mixed UMN + LMN** (often same limb) | EMG (Widespread denervation) | Riluzole, NIV (BiPAP) |\n| **GBS** | Ascending paralysis, Areflexia | LP: Albuminocytologic dissociation | **IVIG or Plasmapheresis** (NO Steroids!) |\n| **Tick Paralysis** | Rapid Ascending paralysis | Find the Tick! | **Remove Tick** (Cure) |\n| **CIDP** | Chronic GBS (>8 weeks) | Nerve Conduction Study | **Steroids** (Differs from GBS) |\n| **Bell's Palsy** | Unilateral facial droop + **Forehead** | Clinical (excludes stroke) | Steroids +/- Acyclovir, Eye care |\n| **Stroke (Face)** | Lower face droop, **Forehead Spared** | MRI Brain | Stroke Protocol |\n---\n### 1. DECOMPOSE: The Neurology Logical Framework (Top-Down Classification)\nì˜í•™ í•™ìŠµì˜ í•µì‹¬ì¸ **Big Picture**ë¥¼ ë¨¼ì € ì¡ê³  ê°‘ì‹œë‹¤! ğŸ§  ì‹ ê²½ê³„ ì§ˆí™˜ì€ ìœ„ì¹˜ì— ë”°ë¼ ì¦ìƒì´ ì™„ì „íˆ ë‹¬ë¼ì§€ê¸° ë•Œë¬¸ì—, ì´ êµ¬ì¡°ë¥¼ ë¨¸ë¦¿ì†ì— ë„£ê³  ì‹œì‘í•´ì•¼ í•©ë‹ˆë‹¤.\nPlaintext\n#\n`NERVOUS SYSTEM PATHOLOGY\nâ”‚\nâ”œâ”€â”€ CENTRAL NERVOUS SYSTEM (UMN: The \"Boss\")\nâ”‚   â”‚   (Brain & Spinal Cord)\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ Stroke (Cortex)\nâ”‚   â”œâ”€â”€ Multiple Sclerosis (White Matter)\nâ”‚   â”œâ”€â”€ Spinal Cord Compression (e.g., Cervical Stenosis)\nâ”‚   â””â”€â”€ B12 Deficiency (Subacute Combined Degeneration)\nâ”‚\nâ”œâ”€â”€ PERIPHERAL NERVOUS SYSTEM (LMN: The \"Worker\")\nâ”‚   â”‚   (Anterior Horn Cell -> Nerve Root -> Nerve -> NMJ -> Muscle)\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ Anterior Horn Cell: Polio, SMA\nâ”‚   â”œâ”€â”€ Nerve Root: Radiculopathy (Herniated Disc)\nâ”‚   â”œâ”€â”€ Peripheral Nerve: \nâ”‚   â”‚   â”œâ”€â”€ Polyneuropathy: GBS, CIDP, Diabetic Neuropathy\nâ”‚   â”‚   â””â”€â”€ Mononeuropathy: Bell's Palsy, Carpal Tunnel\nâ”‚   â”œâ”€â”€ NMJ: Myasthenia Gravis, Lambert-Eaton\nâ”‚   â””â”€â”€ Muscle: Polymyositis, Duchenne\nâ”‚\nâ””â”€â”€ THE HYBRID (UMN + LMN)\n    â””â”€â”€ Amyotrophic Lateral Sclerosis (ALS) â˜…â˜…â˜…`\n---\n### 2. VERIFICATION (0:00 ~ 0:30)\n> \"Welcome back to the deep dive. Today's going to be a little bit intense, but uh, you know, in the best way possible. We are tackling some really high stakes neurology. It's intense because the stakes are high for the patients, and frankly, they're high for anyone gearing up for the USMLE Step 2 CK. This isn't just about passing a test. Right. It's about not missing a diagnosis that could cost someone their mobility or I mean even their life.\"\n>\n---\n### 3. SOLVE: Detailed Lecture Notes ğŸ“\n### Section 1: The Foundation - UMN vs. LMN (The Wiring Diagram) ğŸ”Œ\nì‹ ê²½ê³¼ë¥¼ ì •ë³µí•˜ë ¤ë©´ ì´ \"ë°°ì„ ë„(Wiring)\"ë¥¼ ì´í•´í•´ì•¼ í•©ë‹ˆë‹¤. ì˜¤ë””ì˜¤ì—ì„œëŠ” **Boss vs. Worker** ë¹„ìœ ë¥¼ ì‚¬ìš©í–ˆìŠµë‹ˆë‹¤.\n- **UMN (Upper Motor Neuron - The Boss):** ë‡Œì—ì„œ ì²™ìˆ˜ê¹Œì§€ ëª…ë ¹ì„ ë‚´ë¦¬ëŠ” ì¡´ì¬.\n    - **ì—­í• :** ê·¼ìœ¡ì—ê²Œ \"ì›€ì§ì—¬\"ë¼ê³  ëª…ë ¹ë„ í•˜ì§€ë§Œ, **\"ì§„ì •í•´(Inhibit)\"**ë¼ê³  ì–µì œí•˜ëŠ” ì—­í• ì´ í•µì‹¬!\n    - **ì†ìƒ ì‹œ:** ì–µì œí•˜ëŠ” ë³´ìŠ¤ê°€ ì‚¬ë¼ì§ â†’  ê·¼ìœ¡ì´ ë¯¸ì³ ë‚ ëœ€.\n    - **ì¦ìƒ:** Spasticity (ë‹¨ë‹¨í•¨), Hyperreflexia (ë°˜ì‚¬ í•­ì§„), Babinski sign (+).\n- **LMN (Lower Motor Neuron - The Worker):** ì²™ìˆ˜ì—ì„œ ê·¼ìœ¡ìœ¼ë¡œ ì§ì ‘ ì—°ê²°ë˜ëŠ” ì¼ê¾¼.\n    - **ì—­í• :** ì „ë ¥ì„ ê³µê¸‰í•˜ê³  ì‹¤ì œë¡œ ì›€ì§ì´ê²Œ í•¨.\n    - **ì†ìƒ ì‹œ:** ì „ë ¥ ê³µê¸‰ ì°¨ë‹¨ â†’  ê·¼ìœ¡ì´ êµ¶ì–´ ì£½ìŒ.\n    - **ì¦ìƒ:** Flaccidity (íë¬¼íë¬¼), Atrophy (ìœ„ì¶•), Fasciculations (ì›€ì°”ê±°ë¦¼ - ì£½ì–´ê°€ëŠ” ì‹ í˜¸), Reflex ì†Œì‹¤.\n**ğŸ§ª Clinical Test: Pronator Drift (The Subtle UMN Detector)**\n- **ë°©ë²•:** í™˜ìê°€ ëˆˆì„ ê°ê³  ì†ë°”ë‹¥ì„ í•˜ëŠ˜ë¡œ í–¥í•˜ê²Œ(Pizza box ë“¤ë“¯ì´) íŒ”ì„ ë»—ìŒ.\n- **ì–‘ì„±(Positive):** íŒ”ì´ ì•„ë˜ë¡œ ë–¨ì–´ì§€ë©´ì„œ **ì†ë°”ë‹¥ì´ ì•ˆìª½ìœ¼ë¡œ ëŒì•„ê°(Pronation)**.\n- **ì˜ë¯¸:** Supinator(ì†ë°”ë‹¥ì„ ìœ„ë¡œ í•˜ëŠ” ê·¼ìœ¡)ê°€ Pronator(ì•„ë˜ë¡œ í•˜ëŠ” ê·¼ìœ¡)ë³´ë‹¤ ê¸°ëŠ¥ì ìœ¼ë¡œ ì•½í•´ì¡Œë‹¤ëŠ” ëœ». ì´ëŠ” ë¯¸ì„¸í•œ **UMN Lesion**ì„ ì¡ì•„ë‚´ëŠ” ìµœê³ ì˜ ì‹ ì²´ ê²€ì§„ì…ë‹ˆë‹¤!\n---","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-1"}
{"chunk_type":"transcript_chunk","text":"### Section 2: The Diabetic Trap ğŸ¬ğŸ©¸\n*ë§ì€ í•™ìƒë“¤ì´ ì—¬ê¸°ì„œ í•¨ì •ì— ë¹ ì§‘ë‹ˆë‹¤! ì£¼ì˜í•˜ì„¸ìš”!* ğŸš¨\n- **Scenario:** ë‹¹ë‡¨ë³‘ í™˜ìê°€ ë°œì´ ì €ë¦¬ê³ (Burning, Tingling) ê°ê°ì´ ì—†ë‹¤ê³  ì˜´.\n- **Typical Thought:** \"ì•„, ë‹¹ë‡¨ë³‘ì„± ë§ì´ˆì‹ ê²½ë³‘ì¦(Diabetic Neuropathy)ì´ë„¤. Gabapentin ì£¼ì.\"\n- **THE TRAP:** ë§Œì•½ ë¬´ë¦ ë°˜ì‚¬ë¥¼ ì³¤ëŠ”ë° ë‹¤ë¦¬ê°€ **íŒ! íŠ€ì–´ë‚˜ê°„ë‹¤ë©´(Hyperreflexia)**? í˜¹ì€ ë°œë°”ë‹¥ì„ ê¸ì—ˆë”ë‹ˆ ì—„ì§€ê°€ ì˜¬ë¼ê°„ë‹¤ë©´(Babinski)?\n    - ë‹¹ë‡¨ë³‘ì„± ì‹ ê²½ë³‘ì¦ì€ ë§ì´ˆ ì‹ ê²½(LMN) ë¬¸ì œì´ë¯€ë¡œ ë°˜ì‚¬ê°€ ë–¨ì–´ì ¸ì•¼ ì •ìƒì…ë‹ˆë‹¤.\n    - **â˜… KEY POINT:** ë‹¹ë‡¨ í™˜ìì—ê²Œ **UMN Sign (Hyperreflexia, Babinski)**ì´ ë³´ì´ë©´ ì ˆëŒ€ ë‹¹ë‡¨ íƒ“ì„ í•˜ë©´ ì•ˆ ë¨!\n    - **â˜… Next Best Step:** **MRI of the Spine**. (Cervical/Thoracic Cord Compression, Tumor, or Disc Herniationì„ ì˜ì‹¬í•´ì•¼ í•¨). Burning feet ê³¼ ë‹¤ë¥¸ ì²™ì¶” ì‹ ê²½ê³„ ì§ˆí™˜ì´ ê°™ì´ ì˜¨ ê²ƒ!\n---\n### Section 3: ALS (Amyotrophic Lateral Sclerosis) - The Hybrid Monster ğŸ‘¹\n**ğŸšª Doorway Thought (Room 2):**\në‚˜ì´ ë“  í™˜ì. ì˜¤ë¥¸ì†ì´ ë‘”í•˜ê³  ì•½í•´ì§(Clumsy). ìì„¸íˆ ë³´ë‹ˆ ê·¼ìœ¡ì´ ë§ëê³ (Atrophy), í”¼ë¶€ ë°‘ì—ì„œ ê·¼ìœ¡ì´ ê¿ˆí‹€ê±°ë¦¼(Fasciculations - **LMN**). ê·¸ëŸ°ë° ìµœê·¼ì— ë¬¼ ë§ˆì‹¤ ë•Œ ì‚¬ë ˆê°€ ë“¤ë¦¼(Swallowing issue).\n**1. Concept & Pathophysiology**\n- **Rule Breaker:** ì‹ ê²½ê³¼ ì§ˆí™˜ì€ ë³´í†µ UMN ì•„ë‹ˆë©´ LMNì¸ë°, ALSëŠ” **ë‘˜ ë‹¤(Both)** ë™ì‹œì— ë‚˜íƒ€ë‚©ë‹ˆë‹¤.\n- **Clinical Signature:** í•œ íŒ”ì—ì„œ **Wasted muscle (LMN)**ì„ ë³´ëŠ”ë°, ê·¸ íŒ”ì˜ ë°˜ì‚¬ë¥¼ ì¹˜ë©´ **Hyperactive (UMN)** ë°˜ì‘ì´ ë‚˜ì˜´. â†’  ì´ê±´ 100% ALS ì‹œì‚¬.\n- **Bulbar Symptoms:** ë‡Œê°„(Brainstem)ì˜ ìš´ë™ ì‹ ê²½ì„¸í¬ê°€ ì£½ìœ¼ë©´ì„œ ì‚¼í‚´ ê³¤ë€(Dysphagia), ë°œìŒ ì¥ì• (Dysarthria) ë°œìƒ. â†’  í¡ì¸ì„± íë ´(Aspiration Pneumonia)ì´ ì£¼ ì‚¬ë§ ì›ì¸.\n**2. Diagnosis & Treatment**\n- **â˜… Gold Standard Dx:** **EMG (Electromyography)**. ì „ì‹ ì˜ ê´‘ë²”ìœ„í•œ íƒˆì‹ ê²½(Widespread Denervation) ì†Œê²¬ì„ í™•ì¸.\n- **Tx:** **Riluzole** (Glutamate Inhibitor).\n    - ê¸°ì „: ê³¼ë„í•œ Glutamateê°€ ì‹ ê²½ì„ í¥ë¶„ì‹œì¼œ ì£½ì´ëŠ” ê²ƒ(Excitotoxicity)ì„ ë§‰ìŒ. ìƒëª…ì„ ì•½ê°„ ì—°ì¥í•¨.\n- **Supportive:** í˜¸í¡ ê·¼ìœ¡ì´ ì•½í•´ì§€ë¯€ë¡œ **NIV (Non-invasive Ventilation, e.g., BiPAP)**ê°€ ìƒì¡´ìœ¨ê³¼ ì‚¶ì˜ ì§ˆì— ê°€ì¥ ì¤‘ìš”í•¨.\n---\n### Section 4: Guillain-Barre Syndrome (GBS) - The Ascending Nightmare ğŸªœ\n**ğŸšª Doorway Thought (Room 1):**\nì Šì€ ë‚¨ì. 2ì£¼ ì „ì— ì„¤ì‚¬ë³‘(Stomach bug) ì•“ìŒ. ë‹¤ ë‚«ë‚˜ ì‹¶ë”ë‹ˆ ë°œê°€ë½ì´ ì €ë¦¬ê³  í˜ì´ ë¹ ì§. ì´ í˜ ë¹ ì§ì´ ì ì  ë‹¤ë¦¬ ìœ„ë¡œ ì˜¬ë¼ì˜´(**Ascending Weakness**).\n**1. Pathophysiology: Molecular Mimicry ğŸ­**\n- **ì›ì¸ê· :** *Campylobacter jejuni* (ê°€ì¥ í”í•¨, ëœ ìµì€ ë‹­ê³ ê¸° ë“±), Viral illness.\n- **ê¸°ì „:** ë©´ì—­ ì²´ê³„ê°€ ê· ì„ ê³µê²©í•˜ë ¤ê³  í•­ì²´(Antibody)ë¥¼ ë§Œë“¤ì—ˆëŠ”ë°, ì´ í•­ì²´ê°€ ë§ì´ˆ ì‹ ê²½ì˜ ìˆ˜ì´ˆ(Myelin Sheath)ë¥¼ ê· ìœ¼ë¡œ ì°©ê°í•˜ê³  ê³µê²©í•¨.\n- **ê²°ê³¼:** ì „ì„  í”¼ë³µì´ ë²—ê²¨ì§ â†’  ì‹ ê²½ ì „ë„ ì°¨ë‹¨.\n**2. Clinical Presentation**\n- **Ascending Paralysis:** ë°œ â†’  ë‹¤ë¦¬ â†’  íŒ” â†’  í˜¸í¡ê·¼ (Diaphragm). í˜¸í¡ ë§ˆë¹„ê°€ ì˜¤ë©´ ì‚¬ë§ ê°€ëŠ¥!\n- **Areflexia:** LMN ë¬¸ì œì´ë¯€ë¡œ ì‹¬ë¶€ ê±´ ë°˜ì‚¬(DTR)ê°€ **ì™„ì „íˆ ì‚¬ë¼ì§**. (ë¬´ë¦ ì³ë„ ë°˜ì‘ ì—†ìŒ).\n**3. Diagnosis**","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-21"}
{"chunk_type":"transcript_chunk","text":"- **Lumbar Puncture (LP):** **Albuminocytologic Dissociation** (ë‹¨ë°±ì„¸í¬ í•´ë¦¬).\n    - Protein: **HIGH** (ì—¼ì¦ìœ¼ë¡œ ë‹¨ë°±ì§ˆ ìœ ì¶œ).\n    - WBC (Cell count): **NORMAL** (ì´ê²Œ í•µì‹¬! ë§Œì•½ WBCê°€ ë†’ìœ¼ë©´ ê°ì—¼/ì•” ì˜ì‹¬).\n**4. Treatment (High Yield!)**\n- **â˜… Gold Standard Tx:** **IVIG (Immunoglobulin)** or **Plasmapheresis** (í˜ˆì¥êµí™˜ìˆ  - ë‚˜ìœ í•­ì²´ë¥¼ ê±¸ëŸ¬ëƒ„).\n- **â˜… WARNING:** **Steroids (Prednisone) DO NOT WORK!** ì ˆëŒ€ ì£¼ë©´ ì•ˆ ë¨. (ì˜¤íˆë ¤ íšŒë³µì„ ë°©í•´í•  ìˆ˜ë„ ìˆìŒ).\n- **Vital Sign:** í˜¸í¡ ê¸°ëŠ¥(FVC, NIF) ëª¨ë‹ˆí„°ë§ í•„ìˆ˜. ìˆ¨ ëª» ì‰¬ë©´ ë°”ë¡œ ì‚½ê´€(Intubation).\n---\n### Section 5: The Imposters (GBS Look-alikes) ğŸ•µï¸\n| **Disease** | **Key Feature** | **Diagnosis/Treatment** |\n| --- | --- | --- |\n| **Tick Paralysis** | **Rapidly** Ascending Paralysis (ì‹œê°„/ì¼ ë‹¨ìœ„, GBSë³´ë‹¤ ë¹ ë¦„).\nGBSê³¼ì˜ ì°¨ì´ì : CSFê°€ ì •ìƒ ì†Œê²¬ | **Tx: Remove the Tick!** ğŸ•·ï¸ (ì°¾ì•„ì„œ ë½‘ìœ¼ë©´ ë°”ë¡œ ë‚˜ìŒ) (ê·€ ë’¤ì— ìˆì„ìˆ˜ë„) |\n| **CIDP** | **Chronic** GBS. ì¦ìƒì´ **8ì£¼ ì´ìƒ** ì§€ì†ë¨. | **Tx: Steroids** work here! (GBSì™€ ê°€ì¥ í° ì°¨ì´ì ). |\n| **Miller Fisher** | GBSì˜ ì‚¬ì´Œ. **Triad:** 1. Ophthalmoplegia (ëˆˆ ë§ˆë¹„) 2. Ataxia (ë¹„í‹€ê±°ë¦¼) 3. Areflexia.\nâ€eye wobble, body wobble, no reflexâ€ | antibody: **Anti-GQ1b**. |\n---\n### Section 6: Facial Nerve Palsy (Bell's vs. Stroke) ğŸ­\n**ğŸšª Doorway Thought (Room 3):**\nì¤‘ë…„ ì—¬ì„±, íŒ¨ë‹‰ ìƒíƒœ. ì•„ì¹¨ì— ì¼ì–´ë‚¬ëŠ”ë° ì™¼ìª½ ëˆˆì´ ì•ˆ ê°ê¸°ê³ , ì™¼ìª½ ì–¼êµ´ì´ ì³ì§. ì›ƒìœ¼ë ¤ê³  í•˜ë‹ˆ ì™¼ìª½ ì…ìˆ ì´ ì•ˆ ì›€ì§ì„. \"ì € ë‡Œì¡¸ì¤‘(Stroke) ì¸ê°€ìš”?\"\n**1. The Forehead Rule (ì ˆëŒ€ ì•”ê¸°!) â­**\nì–¼êµ´ ì‹ ê²½ í•´ë¶€í•™ ë•Œë¬¸ì— ë°œìƒí•˜ëŠ” í˜„ìƒì…ë‹ˆë‹¤.\n- **Upper Face (ì´ë§ˆ):** ë‡Œì˜ **ì–‘ìª½(Bilateral)**ì—ì„œ ì‹ í˜¸ë¥¼ ë°›ìŒ. (Backup Generator ìˆìŒ).\n- **Lower Face (ì…):** ë‡Œì˜ **ë°˜ëŒ€ìª½(Contralateral)**ì—ì„œë§Œ ì‹ í˜¸ë¥¼ ë°›ìŒ.\n**2. Differentiation Table**\n| **Feature** | **Bell's Palsy (LMN / Peripheral)** | **Stroke (UMN / Central)** |\n| --- | --- | --- |\n| **Pathology** | Facial Nerve (CN VII) ìì²´ì˜ ì—¼ì¦/ì••ë°•. | ë‡Œ(Cortex)ì˜ ê²½ìƒ‰/ì¶œí˜ˆ. |\n| **Forehead** | **Involved (ì´ë§ˆ ì£¼ë¦„ ëª» ì¡ìŒ)**. ğŸ˜¥ | **Spared (ì´ë§ˆ ì£¼ë¦„ ì¡ì„ ìˆ˜ ìˆìŒ)**. ğŸ¤¨ |\n| **Eye Closure** | ëˆˆì„ ëª» ê°ìŒ (ì•ˆêµ¬ ê±´ì¡° ìœ„í—˜). | ëˆˆ ê°ì„ ìˆ˜ ìˆìŒ (ë³´í†µ). |\n| **Treatment** | Steroids +/- Acyclovir (if viral suspected)\n**Eye Patch/Lubrication** (ì˜ ë•Œ ëˆˆ ë³´í˜¸ í•„ìˆ˜!). â˜…  | Stroke Protocol (MRI, tPA etc.) |\n- **Tip:** í™˜ìê°€ ëˆˆì¹ì„ ì¹˜ì¼œì˜¬ë¦´ ìˆ˜ ìˆë‹¤ë©´(ì´ë§ˆ ì£¼ë¦„ ê°€ëŠ¥) â†’  **STROKE ALERT!** ğŸš¨ (ë‡Œ ì•ˆìª½ ë¬¸ì œë¼ì„œ ë°±ì—… ì‹œìŠ¤í…œì´ ì‘ë™í•œ ê²ƒ).\n- ì•„ì˜ˆ ë‹¤ ë§ˆë¹„ê°€ ë˜ë©´? ì•ˆì¢‹ì•„ë³´ì´ëŠ”ê²Œ ì˜¤íˆë ¤ ì¢‹ì€ê±°ì„.\n- **Lyme Disease**\n    - ì–‘ìª½ì— ì˜¤ê±°ë‚˜, Bullâ€™s eyeê°€ ìˆê±°ë‚˜, ë“±ì‚°í•œ ì´ë ¥ì´ ìˆìœ¼ë©´ ì˜ì‹¬ â˜…\n    - ì–‘ìª½(Bilateral) Bell's Palsyê°€ ì˜¤ë©´ **Lyme Disease** (Borrelia burgdorferi)ë¥¼ ì˜ì‹¬í•´ì•¼ í•¨!\n    - ì˜ì‹¬í•´ì•¼ë˜ëŠ” ì´ìœ : ì¹˜ë£Œê°€ ë‹¬ë¼ì§€ê¸° ë•Œë¬¸ â˜…\n        - Lymeì—ì„œëŠ” ìŠ¤í…Œë¡œì´ë“œ ì£¼ì§€ ì•ŠìŒ (ê°ì—¼ì´ê¸° ë•Œë¬¸)\n        - Doxycycline\n### Section 7: Distal symmetric polyneuropathy\n- stocking and gloves pattern\n    - length dependent: toe ë¶€í„° ì‹œì‘\n- most common seen in clinics\n- Causes:\n    - DM\n    - Uremia (CKD)\n    - Chemotherapy drugs (Cisplatin, Paclitaxel)\n    - HIV (long standing)\n- Management:\n    - Symptoms only: Gabapentin\n---","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-41"}
{"chunk_type":"recap_summary","text":"### 4. RAPID FIRE RECAP: Key Associations ğŸ”¥\n- **Ascending Weakness + Diarrhea hx + CSF high protein normal WBC** â†’  **GBS** (Campylobacter). â†’ ìŠ¤í…Œë¡œì´ë“œ ì•ˆì¤Œ â˜… ! IVIG + plasmaphresis\n- **Ascending Weakness + Camping/Hiking + CSF normal + no fever** â†’  **Tick Paralysis** (Look for the tick!).\n- **Chronic GBS (>8 weeks)** â†’  **CIDP** (Give Steroids).\n- **Atrophy + Hyperreflexia (Mixed)** â†’  **ALS**.\n- **Diabetic with Hyperreflexia** â†’  **Spinal Cord Compression** (MRI Spine).\n- **Facial Droop + Forehead Wrinkles SPARED** â†’  **Stroke**.\n- **Facial Droop + Can't wrinkle forehead** â†’  **Bell's Palsy â†’ eye protection**\n- Facial Droop + Hiker â†’ r/o Lyme â†’ Doxycycline\n- Pronator drift â†’ UMN lesion (í”¼ìê°€ ì—ì–´ì§)\n### 5. SYNTHESIZE & REFLECT\n- **Confidence Score:** 1.0 (Confident).\n- **Caveats:** Audio specifically emphasizes avoiding steroids in GBS but using them in CIDP. Don't mix this up! Also, the distinction between \"Sparing the forehead\" (Central/Stroke) and \"Involving the forehead\" (Peripheral/Bell's) is the most common pimping question in neurology rotation. Memorize the wiring diagram!\n---\n**Next Step for User:** Would you like me to create a detailed **Question Bank (Q-Bank)** style quiz based on these specific clinical vignettes to test your retention?\n**VERIFICATION (0:00 ~ 0:30)**\n\"Welcome back to the deep dive. Today we are, uh, shifting gears. We're not just browsing articles; we are basically doing rounds. We're gonna tackle a really high stakes, high stress topic that is, I mean, absolute gold for the USMLE Step 2 CK. We're talking CNS infections. That's right. And this isn't just a casual chat. Think of this as a high intensity one-on-one tutoring session.\"\n---\n### ğŸ“‹ Overview (TL;DR)","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-61"}
{"chunk_type":"transcript_chunk","text":"ì˜¤ëŠ˜ì˜ **Deep Dive**ëŠ” USMLE Step 2 CKì˜ **High-Yield** í† í”½ì¸ **CNS Infections**ë¥¼ ë‹¤ë£¹ë‹ˆë‹¤. ë‹¨ìˆœí•œ ì•”ê¸°ê°€ ì•„ë‹ˆë¼, ë³‘ë™ ë³µë„ì—ì„œ í™˜ìë¥¼ ë§ˆì£¼ì³¤ì„ ë•Œ(**Doorway Thought**) ì–´ë–¤ ì§ê´€ì„ ê°€ì ¸ì•¼ í•˜ëŠ”ì§€ë¶€í„° ì‹œì‘í•˜ì—¬, **Meningitis, PML, Brain Abscess, Spinal Epidural Abscess**ê¹Œì§€ ì™„ë²½í•˜ê²Œ ì •ë¦¬í•©ë‹ˆë‹¤.\n- **PML**: CD4 < 200, **Non-enhancing** lesion. TreatmentëŠ” ì˜¤ì§ ë©´ì—­ë ¥ íšŒë³µë¿.\n- **Meningitis**: LP ê²°ê³¼ í•´ì„ì´ í•µì‹¬(Neutrophils vs Lymphocytes). SteroidëŠ” í•­ìƒì œ **ì „**ì—.\n- **Brain Abscess**: Ring-enhancing. **Lumbar Puncture ê¸ˆê¸°**.\n- **Spinal Epidural Abscess**: Back pain + Fever + Neuro deficit. **MRI Spine**ì´ ì •ë‹µ. **NEVER LP**.\n---\n### ğŸŒ³ Top-down Classification (Structure)\nì´ ê°•ì˜ì˜ êµ¬ì¡°ë¥¼ í•œëˆˆì— ë³¼ ìˆ˜ ìˆëŠ” **ASCII Text Tree**ì…ë‹ˆë‹¤. ìš°ë¦¬ê°€ ì–´ë””ë¥¼ í•­í•´í•˜ê³  ìˆëŠ”ì§€ í™•ì¸í•˜ì„¸ìš”! ğŸ—ºï¸\nPlaintext\n#\n`CNS INFECTIONS (Deep Dive Map)\n+-- 1. THE DOORWAY THOUGHT (Mental Model & Triage)\n|   +-- Patient A: Meningitis (Stiff neck, Photophobia)\n|   +-- Patient B: Epidural Abscess (Focal back pain, IVDU)\n|\n+-- 2. PARENCHYMAL / WHITE MATTER DISEASE\n|   +-- PML (Progressive Multifocal Leukoencephalopathy)\n|       +-- Concept: JC Virus Reactivation (CD4 < 200)\n|       +-- Imaging: Non-enhancing white matter lesions\n|       +-- Mgmt: Anti-retroviral Therapy (ART)\n|\n+-- 3. MENINGEAL DISEASE (The Heavyweight Champion ğŸ¥Š)\n|   +-- Meningitis Types\n|   |   +-- Bacterial (Neutrophils, Low Glucose)\n|   |   +-- Viral (Lymphocytes, Normal Glucose)\n|   |   +-- TB (Lymphocytes, Very Low Glucose, High Protein)\n|   +-- Management Rules\n|       +-- CT before LP? (FAILS Mnemonic)\n|       +-- Empiric Abx (Vanc + Ceftriaxone +/- Ampicillin)\n|       +-- Steroids (Timing is key!)\n|\n+-- 4. FOCAL MASS LESIONS (Space Occupying)\n|   +-- Brain Abscess\n|       +-- Image: Ring-enhancing lesion\n|       +-- Rule: LP is CONTRAINDICATED â›”\n|       +-- Tx: Drainage + Abx\n|\n+-- 5. SPINAL CORD EMERGENCIES\n    +-- Spinal Epidural Abscess (SEA)\n        +-- Triad: Fever + Back Pain + Neuro Deficit\n        +-- Dx: MRI Spine (Gold Standard) â˜…\n        +-- Tx: Decompression (Surgery) + Abx`\n---\n### ğŸ§  1. The Doorway Thought (Visualizing the Patient)\nì˜¤ë””ì˜¤ì—ì„œëŠ” **\"Doorway Thought\"**ë¼ëŠ” ë©˜íƒˆ ëª¨ë¸ì„ ì œì‹œí•©ë‹ˆë‹¤. ë³‘ì‹¤ ë¬¸ ì•ì— ì„°ì„ ë•Œ, í™˜ìì˜ ì²«ì¸ìƒë§Œìœ¼ë¡œ ê°ë³„ì§„ë‹¨ì„ ì‹œì‘í•˜ëŠ” í›ˆë ¨ì…ë‹ˆë‹¤.\n**Scenario A (Room A)**\n- **Patient:** 20ëŒ€ ëŒ€í•™ìƒ ğŸ§‘â€ğŸ“\n- **Sx:** High fever, Stiff neck (Nuchal rigidity), ì²œì¥ì˜ ë¶ˆë¹›ì„ ëª» ì³ë‹¤ë´„ (**Photophobia**).\n- **Impression:** ì „í˜•ì ì¸ **Meningitis**. ë‡Œê°€ ë¹„ëª…ì„ ì§€ë¥´ê³  ìˆìŒ. \"Lumbar Puncture!\"ë¥¼ ì™¸ì³ì•¼ í•¨.\n**Scenario B (Room B)**\n- **Patient:** IV Drug User (ê³¼ê±°ë ¥ ìˆìŒ) ğŸ’‰\n- **Sx:** Fever, Neck stiffnes ì—†ìŒ, Photophobia ì—†ìŒ. í•˜ì§€ë§Œ **ë“±ì˜ í•œ ê³³ì„ ì°Œë¥´ëŠ” ë“¯í•œ ê·¹ì‹¬í•œ í†µì¦ (Excruciating stabbing pain in one spot on the back)**.\n- **Impression:** ì´ê²ƒì€ **Spinal Epidural Abscess**.\n- **Danger:** ì´ ë‘˜ì„ êµ¬ë¶„ ëª»í•˜ë©´ í°ì¼ ë‚¨. í•˜ë‚˜ëŠ” ë‡Œ íƒˆì¶œ(Herniation), í•˜ë‚˜ëŠ” ì²™ìˆ˜ ë§ˆë¹„(Paralysis)ë¥¼ ìœ ë°œí•¨.\n---\n### ğŸ¦  2. PML (Progressive Multifocal Leukoencephalopathy)\n**\"The Failure of Surveillance\"**\nëª¸ì˜ ê°ì‹œ ì²´ê³„ê°€ ë¬´ë„ˆì¡Œì„ ë•Œ(Immunosuppression) ë°œìƒí•˜ëŠ” ì§ˆí™˜ì…ë‹ˆë‹¤.\n- **Pathophysiology:**\n    - **JC Virus**ì˜ ì¬í™œì„±í™” (Reactivation). ëŒ€ë¶€ë¶„ì˜ ì‚¬ëŒë“¤ì€ ì´ë¯¸ ì´ ë°”ì´ëŸ¬ìŠ¤ë¥¼ ê°€ì§€ê³  ìˆì§€ë§Œ(Dormant), ë©´ì—­ê³„ê°€ ì–µì œí•˜ê³  ìˆìŒ.\n    - ë©´ì—­ì´ ë°”ë‹¥ì„ ì¹˜ë©´(CD4 < 200, Untreated AIDS), ë°”ì´ëŸ¬ìŠ¤ê°€ ê¹¨ì–´ë‚˜ ë‡Œì˜ ì‹ ê²½ì„ ê°ì‹¼ ì ˆì—°ì²´(Myelin)ë¥¼ ë²—ê²¨ë¨¹ê¸° ì‹œì‘í•¨ (**Demyelinating disease**).\n- **Clinical Presentation:**\n    - í­ë°œì ì¸ ì¦ìƒì´ ì•„ë‹˜. ì„œì„œíˆ ë‚˜ë¹ ì§ (**Insidious onset**).\n    - **Clumsy worsening**: Confusion, Paresis, Weakness, Ataxia, Vision changes.\n    - Meningitisì²˜ëŸ¼ ê¸‰ì„±ì´ ì•„ë‹˜.\n- **Diagnosis (Imaging is KEY ğŸ”‘):**\n    - **MRI Brain:** **Asymmetric White Matter Lesions**.\n    - **â˜… CRITICAL POINT:** ì´ ë³‘ë³€ì€ **Enhancement(ì¡°ì˜ ì¦ê°•)ê°€ ì—†ìŒ (Non-enhancing)**. Edema(ë¶€ì¢…)ë„ ì—†ìŒ.\n    - **Why?** EnhancementëŠ” ì—¼ì¦ ë°˜ì‘ìœ¼ë¡œ í˜ˆë¥˜ê°€ ëª°ë¦¬ëŠ” ê²ƒì¸ë°, PML í™˜ìëŠ” ë©´ì—­ê³„ê°€ ë„ˆë¬´ ì•½í•´(CD4 < 200) ì‹¸ì›€ì„ ê±¸ì§€ ëª»í•¨ -> ê·¸ë˜ì„œ ì¡°ì˜ ì¦ê°•ì´ ì•ˆ ë¨.\n        - *Contrast:* Ring-enhancing lesionì´ ë³´ì´ë©´? -> **Toxoplasmosis**ë‚˜ **CNS Lymphoma**ë¥¼ ì˜ì‹¬í•´ì•¼ í•¨.\n- **Confirmation:**\n    - **Lumbar Puncture (LP):** CSFì—ì„œ **JC Virus PCR** ì–‘ì„± í™•ì¸.\n    - Gold StandardëŠ” Brain Biopsyì§€ë§Œ, ë³´í†µ CSF PCRë¡œ ì¶©ë¶„í•¨.\n- **Treatment:**\n    - í•­ë°”ì´ëŸ¬ìŠ¤ì œ? NO âŒ. ì§ì ‘ ì£½ì´ëŠ” ì•½ ì—†ìŒ.\n    - **Management:** **Anti-retroviral Therapy (ART)**. í™˜ìì˜ ë©´ì—­ê³„(Immune system)ë¥¼ ë‹¤ì‹œ ì¬ê±´í•´ì„œ ìŠ¤ìŠ¤ë¡œ ì‹¸ìš°ê²Œ ë§Œë“œëŠ” ê²ƒì´ ìœ ì¼í•œ ë°©ë²•.","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-71"}
{"chunk_type":"transcript_chunk","text":"---\n### ğŸ¥Š 3. Meningitis (The Heavyweight Champion)\nUSMLE ë³´ë“œ ì‹œí—˜ì—ì„œ ê°€ì¥ ë””í…Œì¼í•˜ê²Œ ë¬¼ì–´ë³´ëŠ” íŒŒíŠ¸ì…ë‹ˆë‹¤. **Viral vs. Bacterial vs. TB**ë¥¼ êµ¬ë¶„í•˜ëŠ” ê²ƒì´ í•µì‹¬!\n### ğŸ“Š CSF Analysis Breakdown (The Numbers Game)\n| **Type** | **WBC Count** | **Cell Type** | **Glucose** | **Protein** |\n| --- | --- | --- | --- | --- |\n| **Normal** | 0-5 | - | 40-70 (í˜ˆë‹¹ì˜ 2/3) | < 40 |\n| **Bacterial** ğŸ¦  | > 1,000 (War zone!) | **Neutrophils** â¬†ï¸ | **Low** (< 40) ğŸ”¥ | High (> 250) |\n| **Viral** ğŸ¦  | 100-1,000 (Quieter) | **Lymphocytes** â¬†ï¸ | **Normal** âœ… | Normal/Slight High (< 100) |\n| **TB / Fungal** ğŸ„ | 100-500 | **Lymphocytes** â¬†ï¸ | **Very Low** (< 10) ğŸ“‰ | **Very High** (> 250) ğŸ“ˆ |\n- **Bacterial:** ë°•í…Œë¦¬ì•„ì™€ í˜¸ì¤‘êµ¬(Neutrophil)ê°€ ì„¤íƒ•(Glucose)ì„ ë‹¤ ë¨¹ì–´ì¹˜ì›Œì„œ **Low Glucose**. ì£½ì€ ê· ê³¼ ì„¸í¬ ì‹œì²´ë“¤ ë•Œë¬¸ì— **High Protein**.\n- **Viral:** ë°”ì´ëŸ¬ìŠ¤ëŠ” ì„¤íƒ•ì„ ì•ˆ ë¨¹ìŒ -> **Normal Glucose** (ì´ê²Œ ê°€ì¥ í° íŒíŠ¸! â˜…)\n- **TB:** Lymphocyte + **Super Low Glucose** + High Protein = TB Meningitis.\n### ğŸ’Š Management Strategy (Rapid Fire)\n1. **Empiric Antibiotics (ê²½í—˜ì  í•­ìƒì œ):**\n    - **Standard (Age 2-50):** **Vancomycin + Ceftriaxone**. (Cover S. pneumo & N. meningitidis)\n    - **Age > 50:** ìœ„ ì¡°í•©ì— **+ Ampicillin** ì¶”ê°€ (d/t Listeria: Gram -positive rod)\n    - **Immunocompromised:** Vancomycin + Ampicillin + **Cefepime** (Ceftriaxone ëŒ€ì‹  cefepimeìœ¼ë¡œ ì—…ê·¸ë ˆì´ë“œí•¨. d/t pseudomonas)\n    - Neurosurgery or Trauma: Vancomycin + Cefepime\n2. **Steroids (Dexamethasone):**\n    - ì–¸ì œ? **í•­ìƒì œ ì£¼ê¸° ì „ í˜¹ì€ ë™ì‹œì— (Before or with first dose)**. í•­ìƒì œ ì£¼ê³  ë‚˜ì„œ ì£¼ë©´ íš¨ê³¼ ì—†ìŒ.\n    - ì™œ? ê· ì´ ì£½ìœ¼ë©´ì„œ ìŸì•„ë‚´ëŠ” ì—¼ì¦ ë¬¼ì§ˆì— ì˜í•œ ë‡Œ ì†ìƒ/ì²­ë ¥ ì†ì‹¤ ë°©ì§€ (S. pneumo ì˜ì‹¬ ì‹œ íŠ¹íˆ).\n3. **CT before LP? (Decision Point):**\n    - ì›ì¹™ì ìœ¼ë¡œëŠ” LPë¥¼ ë¹¨ë¦¬ í•´ì•¼ í•˜ì§€ë§Œ, ë‡Œì••ì´ ë†’ì€ ìƒíƒœì—ì„œ ë°”ëŠ˜ì„ ê½‚ìœ¼ë©´ **Brain Herniation** ìœ„í—˜ ìˆìŒ.\n    - **ì–¸ì œ ë‡Œì••ì´ ë†’ì„ì§€ ê±±ì •ë˜ì–´ì„œ CT ì°ì„ì§€ Mnemonic: FAILS**\n    (spinal epidural abscess, brain abscessì¼ë•Œ í•˜ë©´ì•ˆë¨)\n    ****(ì´ ì¤‘ í•˜ë‚˜ë¼ë„ ìˆìœ¼ë©´ CT ë¨¼ì € ì°ì–´ë¼!)\n        - **F** - **F**ocal Neurologic Deficit (ë§ˆë¹„ ë“±) (r/o brain abscess)\n        - **A** - **A**ltered Mental Status (ì˜ì‹ ë³€í™”) (r/o brain abscess)\n        - **I** - **I**mmunosuppression (ë©´ì—­ ì €í•˜) (r/o brain abscess)\n        - **L** - **L**esion (í”¼ë¶€ ë³‘ë³€ ë“±) (puncture site) (r/o spinal epidural abscess)\n        - **S** - **S**eizure (ë°œì‘) (r/o brain abscess)\n        - *Obviously high ICP sign (ìœ ë‘ë¶€ì¢…)*\n    \n4. **Scenario**\n    - Fever, Neck stiffness, alert (ëŒ€ë‹µ ì˜í•¨) : ë°”ë¡œ LP â†’ antibiotics\n    - Confused (Seizure?) or history of HIV? : CT ì´¬ì˜ í›„ LP í•´ì•¼í•¨!\n        - But do no delay treatment!\n        - **Timing:** Blood Culture + Abx ë¨¼ì € ì£¼ê³  -> CT ì°ê³  -> LP\n        (CT ì°ëŠë¼ í•­ìƒì œ ëŠ¦ì¶”ì§€ ë§ˆë¼! â˜…)\n1. **Viralì˜ ê²½ìš°**\n    - ì£¼ë¡œ Conservative Tx.\n    - ì˜ˆì™¸: HSVì˜ì‹¬ë˜ë©´ acyclovir íˆ¬ì—¬\n1. **TBì˜ ê²½ìš°**\n    - Slow burn, chronic\n    - Imaging: basilar meningeal enhancement. (ë°”ë‹¥ì´ ë°ì•„ì§„ë‹¤.)\n        - basilar ì¹¨ë²”!\n        - â†’ cranial nerve palsy\n    - Management: Full anti TB  drugs + Steroids\n---\n### ğŸŒ‹ 4. Brain Abscess (The Pimple in the Brain)\në‡Œ ì‹¤ì§ˆ(Parenchyma) ì•ˆì— ê³ ë¦„ ì£¼ë¨¸ë‹ˆ(Pus pocket)ê°€ ìƒê¸´ ê²ƒ.\n- **Anatomy is Destiny:** ìœ„ì¹˜ë¥¼ ë³´ë©´ ì›ì¸ì„ ì•Œ ìˆ˜ ìˆìŒ.\n    - **Single Lesion:** ì¸ì ‘í•œ ê³³ì—ì„œ ì§ì ‘ ì „íŒŒ (Direct spread).\n        - **Frontal Lobe:** Sinusitis (ë¶€ë¹„ë™ì—¼)ì—ì„œ ë„˜ì–´ì˜´.\n        - **Temporal Lobe / Cerebellum:** Otitis Media (ì¤‘ì´ì—¼) / Mastoiditisì—ì„œ ë„˜ì–´ì˜´.\n    - **Multiple Lesions:** í˜ˆì•¡ íƒ€ê³  ì˜´ (Hematogenous spread).\n        - Endocarditis, Osteomyelitis ë“±.\n        - ì£¼ë¡œ **Grey-White Matter Junction**ì— ìœ„ì¹˜ (í˜ˆê´€ì´ ì¢ì•„ì ¸ì„œ ê· ì´ ê±¸ë¦¬ëŠ” ê³³).\n- **Imaging:**\n    - **Ring-enhancing Lesion** with necrotic center. (ì£¼ë³€ì´ í™˜í•˜ê²Œ ë¹›ë‚˜ëŠ” ê³ ë¦¬ ëª¨ì–‘).\n    - PML(Non-enhancing)ê³¼ ì •ë°˜ëŒ€.\n- **Clinical Triad:**\n    - Headache + Fever + Focal Neuro Deficit. (í•˜ì§€ë§Œ FeverëŠ” 50%ì—ì„œë§Œ ë‚˜íƒ€ë‚¨).\n- **âš ï¸ DO NOT LP (LUMBAR PUNCTURE ê¸ˆê¸°):**\n    - Brain Abscessê°€ ì˜ì‹¬ë˜ë©´ LP ì ˆëŒ€ ê¸ˆì§€. ë‡Œì••ì´ ë†’ì•„ì ¸ **Herniation** ì‚¬ë§ ìœ„í—˜.\n- **Treatment:**\n    - **Aspiration / Surgical Drainage** (ê³ ë¦„ì„ ë¹¼ì•¼ í•¨) + Antibiotics.\n    - í•­ìƒì œë§Œìœ¼ë¡œëŠ” ìº¡ìŠ ë‚´ë¶€ë¡œ ì¹¨íˆ¬ê°€ ì–´ë ¤ì›€.\n---\n### ğŸš¨ 5. Spinal Epidural Abscess (SEA) - A Neurologic Emergency\nì´ê±´ ì •ë§ ë†“ì¹˜ë©´ ì•ˆ ë˜ëŠ” ì‘ê¸‰ ìƒí™©ì…ë‹ˆë‹¤.\n- **Pathology:** Dura(ê²½ë§‰)ì™€ Bone(ì²™ì¶”ë¼ˆ) ì‚¬ì´ ê³µê°„(Epidural space)ì— ê³ ë¦„ì´ ì°¸ -> ì²™ìˆ˜(Spinal Cord)ë¥¼ ëˆ„ë¦„.\n- **Risk Factors:**\n    - **IV Drug Use (Most common)** ğŸ’‰\n    - Spinal procedures (Epidural catheter), Distant infection leading to seeding.\n    - Main Bug: **Staphylococcus aureus** (M.C.)\n- **Classic Triad:**\n    1. **Fever** (50%ë§Œ ìˆìŒ)\n    2. **Severe Focal Back Pain** (êµ­ì†Œì ì´ê³  ê·¹ì‹¬í•œ ë“± í†µì¦ â˜…)\n    3. **Neurologic Deficits** (Weakness, Numbness, Bowel/Bladder issue)\n    - *Warning:* ë§ˆë¹„ê°€ ì˜¤ê¸° ì „ì— í†µì¦ ë‹¨ê³„ì—ì„œ ì¡ì•„ì•¼ í•¨. ë§ˆë¹„ê°€ ì˜¤ë©´ ì˜êµ¬ì ì¼ ìˆ˜ ìˆìŒ.\n- **Diagnosis (The \"Red Flag\" Rule):**\n    - Fever + Severe Back Pain + Risk Factor (IVDU) = **Assume SEA until proven otherwise**.\n    - **Next Best Step:** **MRI of the Spine with Contrast**. (Do NOT wait. Do NOT pass Go).\n    - **LP?** **Absolutely NOT.** âŒ (ë°”ëŠ˜ë¡œ ê³ ë¦„ ì£¼ë¨¸ë‹ˆë¥¼ ì°Œë¥´ë©´ ê· ì„ ì²™ìˆ˜ê°•(Subarachnoid space)ìœ¼ë¡œ ë°€ì–´ ë„£ì–´ì„œ Meningitisë¥¼ ìœ ë°œí•¨).\n- **Treatment:**\n    - **Urgent Surgical Decompression (Laminectomy)** + Drainage + Antibiotics (Vanco + Ceftriaxone/Cefepime).\n    - ìŠ¤í…Œë¡œì´ë“œ? ì—¬ê¸°ì„œëŠ” í¬ê²Œ ë„ì›€ ì•ˆ ë¨. ìˆ˜ìˆ ì´ ë‹µì„ ğŸ”ª.\n---","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-91"}
{"chunk_type":"recap_summary","text":"### ğŸ”¥ Rapid Fire Recap (Summary Table)\n| **Condition** | **Key Feature / Vignette** | **Diagnosis (Gold Standard)** | **Treatment / Mgmt** | **Key Caveat âš ï¸** |\n| --- | --- | --- | --- | --- |\n| **PML** | HIV (CD4 < 200), clumsiness\nAsymmetric white lesion with **Non â˜… -enhancing** lesion | MRI Brain -> CSF JC Virus PCR | HAART (Restore immunity) | No specific antiviral. |\n| **Bacterial Meningitis** | Stiff neck, Photophobia, CSF: **Neutrophils**, **Low Glucose** | LP (CSF Analysis)\nHigh neutrophil, low glucose <40,\nhigh protein >250 | Vanc + Ceftriaxone (+ Ampicillin if >50y) + Steroids | CT before LP if **FAILS** signs present. |\n| **Viral Meningitis** | Similar sx but milder, CSF: **Normal Glucose** | LP (CSF Analysis) | Supportive Care (HSV -> Acyclovir) | Lymphocytes predominant. |\n| **TB Meningitis** | Subacute, CSF: **Very Low Glucose**, High Protein | LP | RIPE Therapy + Steroids | Base of brain enhancement often seen. |\n| **Brain Abscess** | Headache, Focal deficit, **Ring-enhancing** lesion | MRI Brain | **Surgical Drainage** + Abx | **NEVER perform LP** (Herniation risk). |\n| **Spinal Epidural Abscess** | IVDU, **Focal Back Pain**, Fever | **MRI Spine** (w/ contrast) | **Urgent Surgery** + Abx | **NEVER perform LP** (Infection spread). |\n---\n**Confidence Score:** 1.0 (Confident)\n**Key Caveats:**\n- ì´ ê°•ì˜ ë…¸íŠ¸ëŠ” USMLE Step 2 CK ìˆ˜í—˜ìš©ìœ¼ë¡œ ìµœì í™”ë˜ì–´ ìˆìŠµë‹ˆë‹¤. ì‹¤ì œ ì„ìƒì—ì„œëŠ” ë¡œì»¬ ê°€ì´ë“œë¼ì¸ì„ ë”°ë¥´ì„¸ìš”.\n- \"Ring-enhancing\" ë³‘ë³€ì€ Abscess ì™¸ì—ë„ Tumor (Metastasis, Glioblastoma), Toxoplasmosis ë“±ì´ ìˆì„ ìˆ˜ ìˆìœ¼ë‹ˆ ê°ë³„ì´ í•„ìš”í•©ë‹ˆë‹¤.\n- Steroid íˆ¬ì—¬ ì‹œì (Meningitis)ì€ í•­ìƒì œ íˆ¬ì—¬ **ì „**ì´ ê°€ì¥ ì´ìƒì ì´ë¼ëŠ” ì ì„ ê¼­ ê¸°ì–µí•˜ì„¸ìš”. (ì†Œì•„ê³¼/ë‚´ê³¼ ê³µí†µ).\n### ğŸ“‹ Overview: CNS Tumors (Deep Dive)\n**TL;DR Summary Table**\n| **Tumor Type** | **Key Feature/Buzzword** | **Location** | **Key Management/Fact** |\n| --- | --- | --- | --- |\n| **Meningioma** | Dural tail, psammoma bodies | Extra-axial, attached to dura | Resect if symptomatic. Observe if asymptomatic. |\n| **Metastasis** | Gray-white junction, multiple lesions | Intraparenchymal | Most common brain tumor in adults. Lung is most common primary. |\n| **Prolactinoma** | Galactorrhea, amenorrhea | Sella turcica | **Medical therapy first** (dopamine agonist: bromocriptine or cabergoline). |\n| **Craniopharyngioma** | Calcified, cystic, kids (bimodal) | Suprasellar | \"Motor oil\" cyst fluid. Bimodal age distribution. |\n| **Pinealoma** | Parinaud syndrome (upward gaze palsy) | Pineal gland | Compresses dorsal midbrain / superior colliculus. |\n| **Schwannoma** | Hearing loss, tinnitus | Cerebellopontine angle | Bilateral suggests **NF2**. |\n| **Choroid plexus papilloma** | Hydrocephalus (CSF overproduction) | Ventricles | Resection (\"stop the faucet\"). |","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-109"}
{"chunk_type":"transcript_chunk","text":"---\n### ğŸ™ï¸ 1. VERIFICATION (0:00 ~ 0:30)\n> \"All right, welcome back to the deep dive. Today, we're doing things a little differently. We are in full, uh, tutoring mode. That's right, no fluff. This session is built from the ground up for anyone prepping for the USMLE Step 2 CK. We're going to build a solid clinical framework for CNS tumors.\"\n>\n---\n### ğŸŒ³ 2. Top-Down Classification & Mental Model\n**Big Picture & Mental Model ğŸ§ **\nUSMLEì—ì„œ Brain Tumorë¥¼ ì ‘ê·¼í•  ë•Œ ê°€ì¥ ì¤‘ìš”í•œ ê²ƒì€ **\"Location (ìœ„ì¹˜)\"**ì™€ **\"Patient Demographics (í™˜ì ì •ë³´)\"**ì…ë‹ˆë‹¤.\n- **Mental Model:** ë‡ŒëŠ” ë‹«íŒ ìƒì(Skull)ì…ë‹ˆë‹¤. ê³µê°„ì„ ì°¨ì§€í•˜ëŠ” ë©ì–´ë¦¬(Tumor)ê°€ ìƒê¸°ë©´ ì••ë ¥ì´ ì˜¬ë¼ê°‘ë‹ˆë‹¤(ICPâ†‘).\n- **Pathophysiology Impact:**\n    - **Supine Position (ëˆ„ì›Œìˆì„ ë•Œ):** ì¤‘ë ¥ì˜ ë„ì›€ì„ ëª» ë°›ì•„ ë‡Œì˜ ì •ë§¥í˜ˆ(Venous blood) ë°°ì¶œì´ ì¤„ì–´ë“¦ â†’ ICPê°€ ì‚´ì§ ìƒìŠ¹í•¨.\n    - **Tumor Effect:** ì´ë¯¸ Tumorë¡œ ì¸í•´ ê³µê°„ì´ ë¶€ì¡±í•œë° ëˆ•ê¸°ê¹Œì§€ í•˜ë©´? â†’ **\"ì•„ì¹¨ì— ìê³  ì¼ì–´ë‚¬ì„ ë•Œ ë‘í†µì´ ì‹¬í•˜ë‹¤\"** (Worse in morning/lying down)ê°€ ë˜ëŠ” ê²ƒ.\n    - **Valsalva:** ê¸°ì¹¨(Coughing), í˜ì£¼ê¸°(Straining) â†’ í‰ê°• ì••ë ¥ ìƒìŠ¹ â†’ ë‡Œ ì •ë§¥í˜ˆ ë°°ì¶œ ë°©í•´ â†’ ë‘í†µ ì•…í™”.\n**ASCII Text Tree: CNS Tumors Classification**\nPlaintext\n#\n`CNS TUMORS (Approach by Location & Origin)\nâ”‚\nâ”œâ”€â”€ 1. METASTATIC (Secondary) â˜… Most Common in Adults!\nâ”‚   â””â”€â”€ Origin: Lung > Breast > Unknown > Melanoma > Colon\nâ”‚       (Grey-White Junction, Multiple ring-enhancing)\nâ”‚\nâ””â”€â”€ 2. PRIMARY BRAIN TUMORS\n    â”‚\n    â”œâ”€â”€ A. Extra-axial (Brain ë°–ì—ì„œ ëˆ„ë¥´ëŠ” ê²ƒ)\n    â”‚   â”œâ”€â”€ Meningioma (Dura mater origin, Dural tail)\n    â”‚   â””â”€â”€ Schwannoma (CN VIII origin, CP angle)\n    â”‚\n    â”œâ”€â”€ B. Sellar/Suprasellar (Hormone & Vision issues)\n    â”‚   â”œâ”€â”€ Pituitary Adenoma (Prolactinoma etc.)\n    â”‚   â””â”€â”€ Craniopharyngioma (Cystic, Calcified, Children/Elderly)\n    â”‚\n    â”œâ”€â”€ C. Pineal Region (Midbrain compression)\n    â”‚   â””â”€â”€ Pinealoma (Parinaud syndrome)\n    â”‚\n    â””â”€â”€ D. Intraventricular (CSF issues)\n        â””â”€â”€ Choroid Plexus Papilloma (CSF overproduction)`\n---\n### ğŸ¥ 3. The Doorway Thought: Benign vs. Malignant\nì§„ë£Œì‹¤ì— ë“¤ì–´ê°ˆ ë•Œ(Doorway Thought), í™˜ìì˜ ì²«ì¸ìƒë§Œìœ¼ë¡œë„ ê°ë³„ì´ ì‹œì‘ë©ë‹ˆë‹¤.\n### ğŸšª Room A: The Benign Meningioma Track\n- **Patient:** ì¤‘ë…„ ì—¬ì„± (Middle-aged woman).\n- **Presenting Sx:** ì˜¤ëŠ˜ ì•„ì¹¨ ë°œì‘(Seizure) í•¨. ê·¸ ì™¸ì—ëŠ” ê±´ê°•í•¨.\n- **MRI:** ë‡Œë§‰(Covering of the brain)ì— ë¶™ì–´ìˆëŠ” ë©ì–´ë¦¬ + **\"Dural Tail\"** (ê¼¬ë¦¬ì²˜ëŸ¼ ë‡Œë§‰ì´ ë”¸ë ¤ ì˜¬ë¼ê°).\n- **Diagnosis:** **Meningioma** (Benign, ì²œì²œíˆ ìëŒ, ë°–ì—ì„œ ì•ˆìœ¼ë¡œ ëˆ„ë¦„).\n### ğŸšª Room B: The Malignant Metastasis Track\n- **Patient:** ê³¨ì´ˆ(Heavy smoker), ëª¹ì‹œ ë§ˆë¦„(Cachectic), í˜¼ë€ìŠ¤ëŸ¬ì›Œ í•¨(Confusion).\n- **Presenting Sx:** ë‘í†µ, Confusion.\n- **MRI:** **Grey-White Junction**ì— ìœ„ì¹˜í•œ **Multiple Ring-Enhancing Lesions**.\n- **Diagnosis:** **Malignant Metastasis** (Lung cancer ë“±ì—ì„œ ì „ì´).\n---","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-119"}
{"chunk_type":"transcript_chunk","text":"### ğŸ§  4. General Symptoms: Headache (Physics of ICP)\nëª¨ë“  ë‡Œì¢…ì–‘ í™˜ìëŠ” ë‘í†µì„ í˜¸ì†Œí•  ìˆ˜ ìˆìŠµë‹ˆë‹¤. í•˜ì§€ë§Œ **Tumor Headache**ëŠ” íŠ¹ì§•ì´ ìˆìŠµë‹ˆë‹¤.\n- **Mechanism:** ì„œ ìˆì„ ë•Œ(Standing)ëŠ” ì¤‘ë ¥(Gravity)ì´ ë¨¸ë¦¬ì˜ ì •ë§¥í˜ˆ(Venous blood)ì„ ì•„ë˜ë¡œ ë‚´ë ¤ë³´ë‚´ ICPë¥¼ ë‚®ì¶°ì¤ë‹ˆë‹¤. ëˆ„ìš°ë©´(Lying flat) ì´ ë„ì›€ì´ ì‚¬ë¼ì ¸ ICPê°€ ì˜¤ë¦…ë‹ˆë‹¤.\n- **Red Flag Symptoms (ğŸš©):**\n    - \"ì•„ì¹¨ì— ì¼ì–´ë‚  ë•Œ ë‘í†µì´ ì œì¼ ì‹¬í•´ìš”.\" (Wake up with terrible headache).\n    - \"ì¼ì–´ë‚˜ì„œ í™œë™í•˜ë©´ ì¢€ ë‚˜ì•„ì ¸ìš”.\" (Better after up and about).\n    - \"ê¸°ì¹¨í•˜ê±°ë‚˜ í™”ì¥ì‹¤ì—ì„œ í˜ì¤„ ë•Œ ë¨¸ë¦¬ê°€ ê¹¨ì§ˆ ê²ƒ ê°™ì•„ìš”.\" (Worse with Valsalva/Coughing/Bending over) â†’ í‰ê°• ì••ë ¥(Intrathoracic pressure) ì¦ê°€ë¡œ ì¸í•œ ì •ë§¥í˜ˆ ì—­ë¥˜.\n- **Position:** í™œë™ì„± ë‘í†µê³¼ ë‹¬ë¦¬, ëˆ„ìš°ë©´ ì•…í™”ëœë‹¤ëŠ” ì ì´ í•µì‹¬!\n---\n### ğŸ‘ï¸ 5. Sellar Region Masses (The Hormonal Trap)\n**Anatomy Note:** Optic Chiasm(ì‹œì‹ ê²½ êµì°¨)ì´ Sella ë°”ë¡œ ìœ„ì— ì–¹í˜€ ìˆìŠµë‹ˆë‹¤.\n- **Effect:** **Bitemporal Hemianopsia** (ì–‘ì´ì¸¡ ë°˜ë§¹). í„°ë„ ì‹œì•¼(Tunnel vision)ê°€ ìƒê²¨ ë¬¸í‹€(Door frames)ì— ìê¾¸ ë¶€ë”ªí˜.\n### A. Prolactinoma (â˜… USMLE Step 2 Trap!)\nê°€ì¥ í”í•œ ê¸°ëŠ¥ì„± ë‡Œí•˜ìˆ˜ì²´ ì„ ì¢…ì…ë‹ˆë‹¤.\n- **The Trap:** ë³´í†µ ì¢…ì–‘ = ìˆ˜ìˆ ì´ì§€ë§Œ, **ProlactinomaëŠ” ì•½ë¬¼ì´ 1ì°¨ ì¹˜ë£Œ(First Line)**ì…ë‹ˆë‹¤!\n- **Treatment (â˜… Gold Standard):**\n    - **Dopamine Agonist** (Bromocriptine, Cabergoline).\n    - ë„íŒŒë¯¼ì€ Prolactinì„ ì–µì œí•˜ë©°, ì¢…ì–‘ í¬ê¸°(Shrink tumor)ë„ ì¤„ì—¬ì¤ë‹ˆë‹¤.\n    - ìˆ˜ìˆ (Surgery)ì€ ì•½ë¬¼ì´ ì‹¤íŒ¨í•˜ê±°ë‚˜ ì‹œì•¼ ê²°ì†ì´ ê¸‰ê²©í•  ë•Œ ìµœí›„ì˜ ìˆ˜ë‹¨(Last resort)ì…ë‹ˆë‹¤.\n### B. Craniopharyngioma\n- **Origin:** Rathke's Pouch remnants.\n- **Demographics:** Bimodal (ì–´ë¦°ì´ & 50~75ì„¸ ë…¸ì¸).\n- **Imaging Features (The 2 C's):**\n    1. **C**alcified (ì„íšŒí™”).\n    2. **C**ystic (ë‚­ì„±).\n- **Confusing Factor:** ì†Œì•„ ì¢…ì–‘ìœ¼ë¡œ ìœ ëª…í•˜ì§€ë§Œ, ì„±ì¸ì—ì„œë„ ë°œìƒ ê°€ëŠ¥í•˜ë‹ˆ ë‚˜ì´ë¡œ ë°°ì œí•˜ì§€ ë§ ê²ƒ.\n---\n### ğŸ‘€ 6. Pineal Gland Masses (The \"Eye\" Signs)\nPineal gland(ì†¡ê³¼ì²´) ì¢…ì–‘ì€ Dorsal Midbrain(Superior Colliculus)ì„ ëˆ„ë¦…ë‹ˆë‹¤.\n**Clinical Presentation: Parinaud Syndrome (Triad)**\n1. **Limited Upward Gaze:** ìœ„ë¥¼ ì³ë‹¤ë³´ì§€ ëª»í•¨ (\"Sun-setting sign\").\n2. **Upper Eyelid Retraction:** ëˆˆêº¼í’€ì´ ë§ë ¤ ì˜¬ë¼ê°€ì„œ ë…¸ë ¤ë³´ëŠ” ë“¯í•œ ëˆˆ (**Collier sign/stare**).\n3. **Light-Near Dissociation:**\n    - ë¹›(Light)ì„ ë¹„ì¶”ë©´ ë™ê³µ ìˆ˜ì¶• âŒ (No reaction).\n    - ì†ê°€ë½ì„ ì½”ë¡œ ê°€ì ¸ê°€ë©´(Near) ë™ê³µ ìˆ˜ì¶• â­• (Accomodation intact).\n    - \"They react to NEAR, but not to LIGHT\".\n- **Complication:** Cerebral Aqueduct(ì¤‘ë‡Œìˆ˜ë„)ë¥¼ ë§‰ì•„ **Obstructive Hydrocephalus** ìœ ë°œ (êµ¬í† , Ataxia).\n---\n### ğŸ¦€ 7. Metastatic Brain Lesions (The Most Common)\nì„±ì¸ì—ì„œ ê°€ì¥ í”í•œ ë‡Œì¢…ì–‘ì€ Primaryê°€ ì•„ë‹ˆë¼ **Metastasis(ì „ì´ì„±)**ì…ë‹ˆë‹¤.","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-139"}
{"chunk_type":"transcript_chunk","text":"- **Pathophysiology:** ì•”ì„¸í¬(Emboli)ê°€ í˜ˆê´€ì„ íƒ€ê³  ê°€ë‹¤ê°€ í˜ˆê´€ì´ ì¢ì•„ì§€ëŠ” **Grey-White Junction**ì— ê±¸ë¦½ë‹ˆë‹¤.\n- **Result:** í˜ˆì•¡-ë‡Œ ì¥ë²½(BBB)ì´ ê¹¨ì§€ë©´ì„œ ì²´ì•¡ì´ í˜ëŸ¬ë‚˜ì˜´ â†’ **Vasogenic Edema** (ì‹¬í•œ ë¶€ì¢…).\n- **Medical Management:** **Steroids (Dexamethasone)**ê°€ ë¶€ì¢…ì„ ì¤„ì´ê³  BBBë¥¼ ì•ˆì •í™”ì‹œí‚¤ëŠ” ë° ë§¤ìš° íš¨ê³¼ì .\n**Common Sources (Frequency Order)**\n1. **Lung** (ì••ë„ì  1ë“±).\n2. **Breast**.\n3. **Unknown Primary** (ë‡Œ ì „ì´ê°€ ì²« ì¦ìƒì¸ ê²½ìš°ê°€ ë§ìŒ).\n4. **Melanoma** (â˜… íŠ¹ì§•: **Bleeds!** MRIì—ì„œ ì¶œí˜ˆ(Hemorrhage)ì´ ë³´ì´ë©´ ë©œë¼ë…¸ë§ˆ ì˜ì‹¬).\n5. **Colon**.\n**Imaging Tips (MRI)**\n- **Solitary:** Breast, Colon, RCC(ì‹ ì¥)ëŠ” ë‹¨ì¼ ì „ì´ ê²½í–¥.\n- **Multiple:** Lung, MelanomaëŠ” ë‹¤ë°œì„± ì „ì´ ê²½í–¥.\n**Management Algorithm (â˜… Next Best Step)**\n1. **Single Lesion & Fit Patient:** **Surgical Resection** (ì˜ë¼ëƒ„). ìƒì¡´ìœ¨ ì´ë“ì´ ê°€ì¥ í¼.\n2. **Multiple Lesions OR Frail Patient:** **Radiation Therapy** (Stereotactic or Whole Brain Radiation). ìˆ˜ìˆ  ëª»í•¨.\n---\n### ğŸ§© 8. Specific Primary Tumors\n### A. Meningioma (The \"Tail\" Sign)\n- **Imaging:** Extra-axial (ë‡Œ ì‹¤ì§ˆ ë°–), **Homogeneously enhancing** (ê· ì¼í•˜ê²Œ í•˜ì–—ê²Œ ë¨), **Dural Tail** (ê¼¬ë¦¬).\n- **Risk Factors:**\n    - **Female > Male:** Progesterone Receptorë¥¼ ê°€ì§€ê³  ìˆì–´ì„œ ì„ì‹  ì¤‘ í¬ê¸°ê°€ ì»¤ì§ˆ ìˆ˜ ìˆìŒ.\n    - **Radiation:** ê³¼ê±° ë°©ì‚¬ì„  ì¹˜ë£Œ ë³‘ë ¥.\n    - **NF2:** Neurofibromatosis Type 2.\n- **Management:**\n    - **Symptomatic / Large / Edema:** **Surgical Resection**.\n    - **Small / Asymptomatic (ìš°ì—°íˆ ë°œê²¬):** **Serial Imaging (Observation)**. ë°”ë¡œ ìˆ˜ìˆ  ì•ˆ í•¨!.\n### B. Schwannoma (Acoustic Neuroma)\n- **Location:** Cerebellopontine Angle (**CP Angle**).\n- **Origin:** CN VIII (Vestibulocochlear nerve)ì˜ Schwann cell.\n- **Symptoms (Progressive):**\n    1. **Hearing Loss:** Sensorineural (ê°ê°ì‹ ê²½ì„± ë‚œì²­).\n    2. **Tinnitus:** ê·€ìš¸ë¦¼.\n    3. **Vertigo:** ì–´ì§€ëŸ¼ì¦.\n    - *Growth Effect:* ì»¤ì§€ë©´ **CN VII (Facial n.)**ë¥¼ ëˆŒëŸ¬ ì•ˆë©´ ë§ˆë¹„/ê°ê° ì €í•˜, **CN V (Trigeminal)**ë¥¼ ëˆŒëŸ¬ ì–¼êµ´ ê°ê° ì´ìƒ ìœ ë°œ.\n- **Key Association:** **Bilateral(ì–‘ì¸¡ì„±) = NF2 (Neurofibromatosis Type 2)** í™•ì§„.\n- **Dx:** MRI with contrast of Internal Auditory Canal.\n### C. Choroid Plexus Papilloma (The Faucet)\n- **Patient:** ì£¼ë¡œ ì†Œì•„ (Infants/Kids).\n- **Pathophysiology:** Choroid PlexusëŠ” CSF(ë‡Œì²™ìˆ˜ì•¡)ë¥¼ ë§Œë“œëŠ” ê³µì¥ì…ë‹ˆë‹¤. Tumor = ê³¼ë‹¤ ì¦ì‹ = **CSF Overproduction**.\n- **Mechanism:** ìˆ˜ë„ê¼­ì§€ê°€ ê³ ì¥ ë‚˜ì„œ ë¬¼ì´ ì½¸ì½¸ ìŸì•„ì§€ëŠ” ê²ƒê³¼ ê°™ìŒ. í¡ìˆ˜ ì†ë„ê°€ ìƒì‚° ì†ë„ë¥¼ ëª» ë”°ë¼ê°.\n- **Result:** **Hydrocephalus** (Communicating typeì— ê°€ê¹Œì›€, ë§‰íŒ ê²Œ ì•„ë‹ˆë¼ ë„˜ì¹˜ëŠ” ê²ƒ).\n- **Imaging:** ë‡Œì‹¤(Ventricle) ì•ˆì˜ **Lobulated Mass** (ìš¸í‰ë¶ˆí‰í•œ ë©ì–´ë¦¬).\n- **Treatment:** **Surgical Resection** (ìˆ˜ë„ê¼­ì§€ë¥¼ ì ê°€ì•¼ í•¨).\n---","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-159"}
{"chunk_type":"recap_summary","text":"### ğŸ”¥ Rapid Fire Recap & Next Steps\n**Key Clinical Pearls:**\n- **Physical Exam:** ëˆˆì„ ìœ„ë¡œ ëª» ì³ë‹¤ë³´ê³ (Upward gaze palsy) = ì•„ë˜ë¥¼ ì³ë‹¤ë³´ëŠ” ë¶€ë¦…ëœ¨ëŠ” ëˆˆ ë¹›ì— ë°˜ì‘ ì•ˆ í•˜ë©´(Light-near dissociation)? â†’ **Pinealoma**.\n- **History:** ì•„ì¹¨ì— ë‘í†µì´ ì‹¬í•˜ê³  êµ¬í†  í›„ í˜¸ì „? â†’ **Increased ICP**.\n- **Imaging:** Dural Tail? â†’ **Meningioma**.\n- **Imaging:** Grey-White Junctionì— ì—¬ëŸ¬ ê°œ? â†’ **Metastasis**.\n- **Treatment:** ProlactinomaëŠ” ìˆ˜ìˆ  ë¨¼ì €? (NO!) â†’ **Dopamine Agonist**.\n- **Treatment:** Metastasis Single Lesion? â†’ **Resection**. Multiple? â†’ **Radiation**.\n**Caveats:**\n- **Melanoma:** MRIì—ì„œ ì¶œí˜ˆ(Bleeding) ì†Œê²¬ì´ ë³´ì´ë©´ 1ìˆœìœ„ë¡œ ì˜ì‹¬í•  ê²ƒ.\n- **Eyes:** ì‹œë ¥ ê²€ì‚¬ë¿ë§Œ ì•„ë‹ˆë¼ ì‹œì•¼(Visual field) ê²€ì‚¬ë¥¼ í†µí•´ Sellar massë¥¼ ë†“ì¹˜ì§€ ë§ ê²ƒ.\n- female pt. seizure, dural tail â†’ meningioma\n- no1 primary for mets brain ca â†’ lung ca\n- bilateral vestibular schwannoma â†’ NF2\n- schwanomma hearing loss ì™¸ ë‹¤ë¥¸ ì¦ìƒ..? â†’ facial numbness (CN5), facial palsy (CN7)\n- calcified sellar mass â†’ craniopharyngioma\n**Next Step for User:**\nWould you like me to generate a **USMLE-style vignettes quiz** based on these tumors to test your retention? (e.g., \"A 45-year-old woman with hearing loss...\" scenarios?)\n### ğŸ“‹ Overview: Pediatric Neurology (Congenital & Developmental)\nì•ˆë…•í•˜ì„¸ìš”! ğŸ‘¨â€âš•ï¸ ì˜¤ëŠ˜ì€ **Pediatric Neurology**, ê·¸ì¤‘ì—ì„œë„ ì„ ì²œì„± ì§ˆí™˜ê³¼ ë°œë‹¬ ë¬¸ì œë¥¼ ë‹¤ë£¹ë‹ˆë‹¤. í”¼ë¶€ ì†Œê²¬(Skin)ì´ ë‡Œ(Brain)ì˜ ìƒíƒœë¥¼ ë§í•´ì£¼ëŠ” **Neurocutaneous disorders**ë¶€í„°, ë“±(Spine)ì˜ ë¬¸ì œ, ë¨¸ë¦¬ í¬ê¸°(Head size), ê·¸ë¦¬ê³  ë‡Œì„±ë§ˆë¹„(CP)ê¹Œì§€! **USMLE High-Yield** í¬ì¸íŠ¸ë“¤ì„ ê½‰ê½‰ ì±„ì›Œë“œë¦´ê²Œìš”. ğŸ§","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-175"}
{"chunk_type":"transcript_chunk","text":"ì´ ê°•ì˜ì˜ í•µì‹¬ì€ **\"Outside-In Approach\"**ì…ë‹ˆë‹¤. ê²‰ìœ¼ë¡œ ë³´ì´ëŠ” í”¼ë¶€ë‚˜ ì²™ì¶”ì˜ ì†Œê²¬ì´ ì•ˆìª½ì˜ ì‹ ê²½ê³„ ë¬¸ì œë¥¼ ë°˜ì˜í•œë‹¤ëŠ” ê²ƒì´ì£ ! (Embryology: Skin & Brain = Both Ectoderm origin ğŸ‘¯â€â™‚ï¸)\n---\n### ğŸ” VERIFICATION (0:00 ~ 0:30)\n> \"I want you to picture a scenario. You're walking into a patient room for a routine newborn exam. On the table, there's a baby, maybe two days old, and from the front, everything looks perfect. Cute, chubby, squirming. But then, you turn the infant over to check the spine, and right there, just above the gluteal crease, you see something... a little odd.\"\n>\n---\n### ğŸŒ³ Top-Down Classification: Pediatric Neurology (Congenital)\nPlaintext\n`Pediatric Neurology (Congenital & Developmental)\nâ”‚\nâ”œâ”€â”€ 1. Neurocutaneous Disorders (Phakomatoses) ğŸ§¬\nâ”‚   â”œâ”€â”€ NF1 (Neurofibromatosis Type 1) - Skin & Bone\nâ”‚   â”œâ”€â”€ NF2 (Neurofibromatosis Type 2) - Ears & Eyes\nâ”‚   â”œâ”€â”€ Tuberous Sclerosis (TSC) - Multi-system Chaos\nâ”‚   â”œâ”€â”€ Von Hippel-Lindau (VHL) - Vascular Tumors\nâ”‚   â””â”€â”€ Sturge-Weber Syndrome - Port Wine & Seizures\nâ”‚\nâ”œâ”€â”€ 2. Neural Tube Defects (Spine) ğŸ¦´\nâ”‚   â”œâ”€â”€ Spina Bifida Occulta (Hidden)\nâ”‚   â”œâ”€â”€ Meningocele (Sac with fluid)\nâ”‚   â””â”€â”€ Myelomeningocele (Sac with nerves - Severe)\nâ”‚\nâ”œâ”€â”€ 3. Scalp Swellings (Newborn Head Lumps) ğŸ¤•\nâ”‚   â”œâ”€â”€ Caput Succedaneum (Edema)\nâ”‚   â”œâ”€â”€ Cephalohematoma (Blood, Sub-periosteal)\nâ”‚   â””â”€â”€ Subgaleal Hemorrhage (Dangerous!)\nâ”‚\nâ”œâ”€â”€ 4. Head Size Anomalies ğŸ“\nâ”‚   â”œâ”€â”€ Hydrocephalus (Water on brain)\nâ”‚   â”œâ”€â”€ Microcephaly (Small head)\nâ”‚   â””â”€â”€ Macrocephaly (Big head)\nâ”‚\nâ””â”€â”€ 5. Cerebral Palsy (Motor) â™¿\n    â”œâ”€â”€ Spastic Diplegia (Prematurity)\n    â””â”€â”€ Hemiplegia (Stroke/Vascular)`\n---\n### 1. Neurocutaneous Disorders (The Phakomatoses) ğŸ§¬\n**Core Concept:** í”¼ë¶€(Skin)ì™€ ë‡Œ(Nervous System)ëŠ” ë°œìƒí•™ì ìœ¼ë¡œ ëª¨ë‘ **Ectoderm(ì™¸ë°°ì—½)**ì—ì„œ ìœ ë˜í•œ ìŒë‘¥ì´ì…ë‹ˆë‹¤. í”¼ë¶€ì˜ \"Blueprints\"ê°€ ì—‰ë§ì´ë¼ë©´(messy), ì‹ ê²½ê³„ì˜ \"Blueprints\"ë„ ì—‰ë§ì¼ í™•ë¥ ì´ ë†’ìŠµë‹ˆë‹¤! ğŸš©\n### A. Neurofibromatosis Type 1 (NF1)\n- **Genetic:** Mutation in **NF1 gene** on **Chromosome 17**.\n    - *Mnemonic:* von Recklinghausen's disease (ì´ë¦„ì´ ê¸¸ì£ ? 17ê¸€ì ì •ë„ ë¨ â†’  Chr 17)\n- **Protein:** **Neurofibromin** (Tumor Suppressor, RAS pathwayì˜ break pedal ì—­í• ). ë¸Œë ˆì´í¬ê°€ ê³ ì¥ ë‚˜ì„œ ì„¸í¬ê°€ ê³„ì† ë¶„ì—´í•¨.\n- **Clinical Presentation (Doorway Clues):**\n    - **Skin:** **CafÃ©-au-lait spots** â˜• (6ê°œ ì´ìƒì´ì–´ì•¼ í•¨). \"Spilled latte look\".\n    - **Axillary/Inguinal Freckling:** ê²¨ë“œë‘ì´ë‚˜ ì‚¬íƒ€êµ¬ë‹ˆì˜ ì£¼ê·¼ê¹¨.\n    - **Eye:** **Lisch Nodules** (Irisì˜ ê°ˆìƒ‰ ë©ì–´ë¦¬ë“¤ - Visionì—ëŠ” ì˜í–¥ ì—†ìŒ, ì§„ë‹¨ì  ê°€ì¹˜ë§Œ ìˆìŒ).\n    - **Tumors:** **Neurofibromas** (í”¼ë¶€ ë°‘ì˜ ë§ë‘ë§ë‘í•œ ë©ì–´ë¦¬, 'Button-hole' sign), Optic Glioma.\n    - **Bone:** Skeletal dysplasia.\n### B. Neurofibromatosis Type 2 (NF2)\n- **Genetic:** Mutation in **NF2 gene** on **Chromosome 22**.\n    - *Mnemonic:* Type 2ë‹ˆê¹Œ 2ê°€ ë‘ ê°œ â†’  22ë²ˆ ì—¼ìƒ‰ì²´.\n- **Protein:** **Merlin** (ì„¸í¬ ê³¨ê²© ì•ˆì •í™” ë‹¨ë°±ì§ˆ). Schwann cellì´ ë¯¸ì¹œ ë“¯ì´ ìë¼ë‚¨.\n- **Clinical Presentation:**\n    - **Ears (â˜…Key):** **Bilateral Vestibular Schwannomas** (Acoustic Neuromas).\n        - ì¦ìƒ: Hearing loss, Tinnitus (ì´ëª…), Balance issues.\n    - **Eyes:** **Juvenile Cataracts** (ë°±ë‚´ì¥).\n    - *Note:* Skin findingì€ NF1ë³´ë‹¤ í›¨ì”¬ ì ìŒ.\n### C. Tuberous Sclerosis Complex (TSC)\n- **Genetic:** TSC1 or TSC2 mutation. **mTOR pathway** ì¡°ì ˆ ì‹¤íŒ¨ â†’  \"Multi-system Chaos\" (ë‡Œ, í”¼ë¶€, ì‹¬ì¥, ì‹ ì¥ ë‹¤ ì»¤ì§).\n- **Clinical Presentation:**\n    - **Skin (â˜…First Sign):** **Ash-leaf spots** (Hypopigmented macules).\n        - **Next Best Step:** **Wood's Lamp** (UV light) examination to see them clearly.\n    - **Face:** **Adenoma Sebaceum** (Facial Angiofibromas) - ì½”ì™€ ëº¨ ì£¼ë³€ì˜ ë¶‰ì€ ì—¬ë“œë¦„ ê°™ì€ ê²ƒë“¤ (Acneì™€ ë‹¬ë¦¬ ë”±ë”±í•˜ê³  í”¼ê°€ ì˜ ë‚¨).\n    - **Back:** **Shagreen Patch** (Orange peel/Leather texture).\n    - **Fingers:** **Ungual Fibromas** (ì†í†± ì£¼ë³€ì˜ ì„¬ìœ ì¢…).\n    - **Brain:** **Cortical Tubers**, **Subependymal Giant Cell Astrocytoma (SEGA)**.\n        - â†’  ì›ì¸ ë¶ˆëª…ì˜ **Seizures** (íŠ¹íˆ Infantile Spasms - West Syndrome) + Intellectual Disability / Autism.\n    - **Heart:** **Cardiac Rhabdomyoma** (ì‹ ìƒì•„ ì‹¬ì¥ ì¢…ì–‘ì˜ m/c cause).\n    - **Kidney:** **Renal Angiomyolipoma**.\n### D. Von Hippel-Lindau (VHL)\n- **Genetic:** VHL gene on **Chromosome 3**. (VHL ì„¸ ê¸€ì â†’  3ë²ˆ)\n- **Protein:** pVHL (HIF-1a ë¶„í•´). ì´ê²Œ ê³ ì¥ ë‚˜ë©´ ëª¸ì´ \"ì‚°ì†Œ ë¶€ì¡±í•´!\"ë¼ê³  ì°©ê°í•´ì„œ í˜ˆê´€ì„ ë§ˆêµ¬ ë§Œë“¦ (Angiogenesis).\n- **Clinical Presentation (Tumors everywhere):**\n    - **Hemangioblastomas:** Retina (Vision loss), Cerebellum (Balance issues).\n    - **Renal Cell Carcinoma (RCC):** ì‹ ì¥ì•” (Clear cell type).\n    - **Pheochromocytoma:** ë¶€ì‹  ì¢…ì–‘.\n### E. Sturge-Weber Syndrome","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-185"}
{"chunk_type":"transcript_chunk","text":"- **Genetic:** **Somatic Mosaicism** (GNAQ gene). **NOT Inherited!** (ìœ ì „ë˜ì§€ ì•ŠìŒ).\n- **Pathology:** í˜ˆê´€ ê¸°í˜•(Vascular malformation). \"GNAQ mutation\"\n- **Clinical Presentation:**\n    - **Face:** **Port-Wine Stain** (Nevus Flammeus) in **V1/V2 distribution** (Trigeminal nerve).\n    - **Brain:** ê°™ì€ ìª½(Ipsilateral) ë‡Œë§‰ì˜ **Leptomeningeal Angioma**.\n        - abnormal vein â†’ congestion â†’ í˜ˆë¥˜ê³µê¸‰ â†“\n        - ë‡Œê°€ ì„íšŒí™”ë¨ (Tram-track Calcifications).\n        - â†’  ë‡Œê°€ ì„íšŒí™”ë¨ (**Tram-track Calcifications**).\n        - â†’  ë°˜ëŒ€ìª½(Contralateral) **Seizures** & **Hemiparesis** (í¸ë§ˆë¹„).\n    - **Eye:** **Glaucoma** (ë…¹ë‚´ì¥) - ì•ˆì•• ìƒìŠ¹ ì£¼ì˜! ğŸ‘ï¸Â (í˜ˆë¥˜ ë¬¸ì œ â†’ ì••ë ¥ ìƒìŠ¹ìœ¼ë¡œ ì¸í•´ ë…¹ë‚´ì¥ìƒê¹€)\n---\n### 2. Neural Tube Defects (Spina Bifida) ğŸ¦´\n**Mechanism:** Neural tubeê°€ ì œëŒ€ë¡œ ë‹«íˆì§€ ì•Šì€ \"Zipper\" ê³ ì¥.\n**Prevention:** **Folic Acid (ì—½ì‚°)** ì„­ì·¨ê°€ í•„ìˆ˜! (Maternal deficiencyê°€ ì£¼ì›ì¸)\n### Types (Severity ìˆœì„œ)\n1. **Spina Bifida Occulta (Hidden):**\n- ë¼ˆ(Vertebrae)ë§Œ ì•ˆ ë‹«í˜. ì²™ìˆ˜ëŠ” ì •ìƒ.\n- **Sign:** í—ˆë¦¬ ì•„ë˜ìª½(Gluteal crease ìœ„)ì— **Tuft of Hair** (í„¸ ë­‰ì¹˜), Dimple, or Lipoma.\n- **Complication:** **Tethered Cord Syndrome** (ì²™ìˆ˜ê°€ ë¼ˆì— ë“¤ëŸ¬ë¶™ì–´ í‚¤ê°€ í´ ë•Œ ì²™ìˆ˜ê°€ ë‹¹ê²¨ì§ â†’  Bladder/Bowel dysfunction, Leg weakness).\n![image.png](LM_Neuro%203/image.png)\n![image.png](LM_Neuro%203/image%201.png)\n1. **Meningocele:**\n    - ì£¼ë¨¸ë‹ˆ(Sac)ê°€ íŠ€ì–´ë‚˜ì˜´. ì•ˆì—ëŠ” **Fluid(CSF)**ì™€ Meningesë§Œ ìˆìŒ. ì‹ ê²½(Nerve)ì€ ì—†ìŒ.\n2. **Myelomeningocele (ê°€ì¥ ì‹¬ê°):**\n    - ì£¼ë¨¸ë‹ˆ ì•ˆì— **Spinal Cord(Nerve)**ê°€ ë“¤ì–´ìˆìŒ.\n    - ì¦ìƒ: í•´ë‹¹ ë ˆë²¨ ì´í•˜ì˜ ë§ˆë¹„(Paralysis), ê°ê° ì†Œì‹¤. **Chiari II Malformation** (ì†Œë‡Œê°€ ì²™ìˆ˜ë¡œ ë¹ ì§) ë° **Hydrocephalus** ë™ë°˜ ê°€ëŠ¥ì„± ë†’ìŒ.\n### Management with Bladder Problems\n- urinary catheter ìì£¼ ë„£ì–´ì¤˜ì„œ ì˜¤ì¤Œ ëºŒ to prevent kidney problems.\n---\n### 3. Scalp Swellings (Newborn Head Lumps) ğŸ¤•\nì‹ ìƒì•„ê°€ íƒœì–´ë‚  ë•Œ ë¨¸ë¦¬ì— í˜¹ì´ ë‚¬ë‹¤? ì¸µ(Layer)ì„ ì•„ëŠ” ê²ƒì´ ì¤‘ìš”í•©ë‹ˆë‹¤!\n![image.png](LM_Neuro%203/image%202.png)\n| **íŠ¹ì§•** | **Caput Succedaneum = ë©** | **Cephalohematoma = â€˜í”¼â€™ë©** | **Subgaleal Hemorrhage\n=ë„“ì€ ê³µê°„ì— í”¼ì°¸** |\n| --- | --- | --- | --- |\n| **ìœ„ì¹˜** | Skin (Subcutaneous) | Under Periosteum (ê³¨ë§‰ ì•„ë˜) | Subgaleal space (Emissary veins) |\n| **ë‚´ìš©ë¬¼** | Serosanguinous fluid (Edema) | **Blood** | **Blood** (Massive) |\n| **Suture Line** | **Crosses Sutures** (ë§‰ ê±´ë„ˆê°) | **Does NOT Cross** (ë¼ˆì— ê°‡í˜) | **Crosses Sutures** (ê·€ì—ì„œ ê·€ê¹Œì§€) |\n| **ëŠë‚Œ** | Soft, Boggy (ë¬¼ë ë¬¼ë ) | Firm boundaries (ë‹¨ë‹¨í•¨) | Boggy, diffuse waves (ì¶œë ê±°ë¦¼) |\n| **ìœ„í—˜ë„** | Benign (ë©°ì¹  ë‚´ ì‚¬ë¼ì§) | **Hyperbilirubinemia** (í™©ë‹¬) | **Life-Threatening** (Shock!) ğŸš¨ |\n| **Note** | \"Caput\" = Cap(ëª¨ì)ì„ ì“°ë©´ ë´‰í•©ì„ ì„ ë„˜ì–´ê°€ë“¯. | ë¼ˆ ëª¨ì–‘ ê·¸ëŒ€ë¡œ í˜¹ì´ ë‚¨. | í”¼ê°€ ì—„ì²­ë‚˜ê²Œ ê³ ì—¬ì„œ ì‡¼í¬ì‚¬ ê°€ëŠ¥. |\n---\n### 4. Head Size Anomalies ğŸ“","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-205"}
{"chunk_type":"transcript_chunk","text":"### A. Hydrocephalus (ìˆ˜ë‘ì¦)\n- **Concept:** \"Plumbing issue\". CSFê°€ ë¹ ì ¸ë‚˜ê°€ì§€ ëª»í•¨ (Obstruction) or ë„ˆë¬´ ë§ì´ ìƒì„±ë¨.\n- **Symptoms:**\n    - Rapidly increasing head circumference.\n    - **Bulging Fontanelle** (ëŒ€ì²œë¬¸ íŒ½ì°½).\n    - **Sun-set Eyes:** ëˆˆì´ ì•„ë˜ë¡œ ê¹”ë¦¼ (Midbrain pressure â†’  Upward gaze palsy).\n- **Cause:** Intraventricular Hemorrhage (Preemie), Tumors, Chiari Malformation.\n### B. Microcephaly (ì†Œë‘ì¦)\n- **Definition:** Head circumference **< 3rd percentile**.\n- **Algorithm (First Step):**\n    - **Measure Mom & Dad's heads!** ğŸ‘¨â€ğŸ‘©â€ğŸ‘§\n    - ë¶€ëª¨ ë¨¸ë¦¬ê°€ ì‘ë‹¤? â†’  **Benign Familial Microcephaly** (No workup needed).\n    - ë¶€ëª¨ëŠ” ì •ìƒì´ë‹¤? â†’  Pathologic (Zika virus, Genetic, TORCH infection ë“±).\n### C. Macrocephaly (ëŒ€ë‘ì¦)\n- **Definition:** Head circumference **> 97th percentile**.\n- **Causes:** Hydrocephalus, Familial, Canavan disease, Alexander disease etc.\n---\n### 5. Cerebral Palsy (CP) â™¿\n**Definition:** **Permanent, NON-progressive** motor disorder. (ë‡Œ ì†ìƒ;ì£¼ë¡œ í˜ˆë¥˜ ì†ìƒ ë¬¸ì œ;ì€ í•œ ë²ˆ ì¼ì–´ë‚¬ê³ , ë” ë‚˜ë¹ ì§€ì§€ëŠ” ì•ŠìŒ. ì¦ìƒì€ ì•„ì´ê°€ í¬ë©´ì„œ ë‹¬ë¼ ë³´ì¼ ìˆ˜ ìˆìŒ).\n### A. Spastic Diplegia (ì–‘í•˜ì§€ ë§ˆë¹„)\n- **Risk Factor:** **Prematurity** (ë¯¸ìˆ™ì•„).\n- **Pathophysiology:** **Periventricular Leukomalacia (PVL)**.\n    - ë‡Œì‹¤ ì£¼ë³€(Periventricular)ì˜ White matterê°€ ê´´ì‚¬í•¨. ì´ê³³ì— **ë‹¤ë¦¬(Legs)**ë¡œ ê°€ëŠ” ìš´ë™ ì‹ ê²½ì´ ì§€ë‚˜ê°.\n    - ë¯¸ìˆ™ì•„ëŠ” í˜ˆë¥˜ ë°œì „ì´ ì˜ë˜ì§€ ì•Šì•„ì„œ ì €ë¶€ë¶„ì´ ischemic changeì— ì·¨ì•½í•¨.\n- **Presentation:**\n    - **Legs > Arms** (ë‹¤ë¦¬ê°€ ë” ë»£ë»£í•˜ê³  ì•½í•¨).\n    - **\"Commando Crawl\"**: íŒ”ë¡œë§Œ ê¸°ì–´ ë‹¤ë‹ˆê³  ë‹¤ë¦¬ëŠ” ì§ˆì§ˆ ë”. ğŸª–\n    - **Scissoring gait**: ê±¸ì„ ë•Œ ë‹¤ë¦¬ê°€ ê°€ìœ„ì²˜ëŸ¼ êµì°¨ë¨.\n### B. Spastic Hemiplegia (í¸ë§ˆë¹„)\n- **Risk Factor:** Perinatal Stroke, Vascular insult.\n- **Presentation:** ëª¸ì˜ í•œìª½(Left or Right)ë§Œ ë§ˆë¹„.\n- **â˜… Red Flag:** **Early Hand Preference (< 18 months)**.\n    - 18ê°œì›” ì´ì „ì— ì˜¤ë¥¸ì†ì¡ì´/ì™¼ì†ì¡ì´ê°€ ëšœë ·í•˜ë‹¤ë©´? ë°˜ëŒ€ìª½ ì†ì„ *ëª» ì¨ì„œ* ê·¸ëŸ´ ìˆ˜ ìˆìŒ. ì´ëŠ” Hemiparesisì˜ ê°•ë ¥í•œ ì‹ í˜¸!\n### Management\n- **Goal:** Functionality & Comfort.\n- **Tx:** **Botox** injections (ê·¼ìœ¡ ì´ì™„), **Baclofen** (GABA agonist - spasticity ê°ì†Œ), Physical Therapy.\n---","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-225"}
{"chunk_type":"recap_summary","text":"### âš¡ Rapid Fire Recap (Summary Table)\n| **Condition** | **Key Clinical Feature / Buzzword** | **Pathophysiology / Gene** |\n| --- | --- | --- |\n| **NF1** | CafÃ©-au-lait, Lisch nodules, Neurofibromas | Chr 17, Neurofibromin |\n| **NF2** | **Bilateral Acoustic Neuromas** (Hearing loss) | Chr 22, Merlin |\n| **Tuberous Sclerosis** | **Ash-leaf spots**, Cardiac Rhabdomyoma, Seizures | TSC1/2, mTOR pathway |\n| **Sturge-Weber** | **Port-Wine Stain**, Seizures (Contralateral) | Somatic GNAQ (Not inherited) |\n| **VHL** | Hemangioblastomas (Retina/Cerebellum), RCC | Chr 3, VHL gene |\n| **Cephalohematoma** | Does **NOT** cross sutures | Subperiosteal blood (Risk: Jaundice) |\n| **Subgaleal Hemorrhage** | **Crosses** sutures, Fluctuant | Emissary veins (Risk: Shock/Death) |\n| **Spastic Diplegia** | **Commando Crawl**, Legs > Arms | Prematurity â†’  PVL |\n---\n**Confidence Score:** 1.0 (Confident)\n**Key Caveats:**\n- ì˜¤ë””ì˜¤ ê°•ì˜ëŠ” \"General Rule\"ì„ ë‹¤ë£¹ë‹ˆë‹¤. ì˜ˆì™¸ì ì¸ ì¼€ì´ìŠ¤(Mosaicism in NF, etc.)ëŠ” í•­ìƒ ì¡´ì¬í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n- CPì˜ ì§„ë‹¨ì€ ì„ìƒì (Clinical)ì´ì§€ë§Œ, í™•ì§„ì„ ìœ„í•´ MRIê°€ í•„ìš”í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n- Scalp swelling ì¤‘ Subgaleal hemorrhageëŠ” ì‘ê¸‰ ìƒí™©ì„ì„ ê¼­ ê¸°ì–µí•˜ì„¸ìš”!\n**Overview: Pediatric Acute Neurology Deep Dive**\nì•ˆë…•í•˜ì„¸ìš”! ì˜¤ëŠ˜ì€ ì†Œì•„ ì‘ê¸‰ ì‹ ê²½í•™(Pediatric Acute Neurology)ì— ëŒ€í•´ ì•„ì£¼ ê¹Šì´ ìˆê²Œ íŒŒê³ ë“¤ì–´ ë³´ê² ìŠµë‹ˆë‹¤. ğŸ§ âš¡ï¸ ë¯¸êµ­ ì˜ì‚¬ êµ­ê°€ê³ ì‹œ(USMLE)ë‚˜ ì„ìƒ í˜„ì¥ì—ì„œ ì •ë§ ì¤‘ìš”í•˜ê²Œ ë‹¤ë£¨ëŠ” **Stroke, IVH, ê·¸ë¦¬ê³  ë‹¤ì–‘í•œ Pediatric Epilepsy Syndromes**ë¥¼ ë‚˜ì´ëŒ€ë³„, ìƒí™©ë³„ë¡œ ì™„ë²½í•˜ê²Œ ì •ë¦¬í•´ ë“œë¦´ê²Œìš”.\nì´ ê°•ì˜ëŠ” \"High-Yield Tutoring Session\" ì»¨ì…‰ìœ¼ë¡œ ì§„í–‰ë©ë‹ˆë‹¤. ë†“ì¹˜ëŠ” ë‚´ìš© ì—†ì´ ê½‰ê½‰ ì±„ì› ìœ¼ë‹ˆ ì§‘ì¤‘í•´ ì£¼ì„¸ìš”! ğŸ”¥\n### **Top-down Classification & Structure (ASCII Text Tree)**","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-241"}
{"chunk_type":"transcript_chunk","text":"ì´ êµ¬ì¡°ë¥¼ ë¨¸ë¦¿ì†ì— ë¨¼ì € ë„£ê³  ì„¸ë¶€ ë‚´ìš©ì„ ì±„ì›Œë„£ìœ¼ì„¸ìš”. ğŸŒ³\nPlaintext\n`Pediatric Acute Neurology (ì†Œì•„ ê¸‰ì„± ì‹ ê²½í•™)\nâ”‚\nâ”œâ”€â”€ 1. Acute Hemiplegia (ê¸‰ì„± í¸ë§ˆë¹„: The Scary Door)\nâ”‚   â”œâ”€â”€ Ischemic Stroke (í—ˆí˜ˆì„± ë‡Œì¡¸ì¤‘)\nâ”‚   â”‚   â””â”€â”€ ì›ì¸: Cardiac defects, Sickle cell, Prothrombotic d/o\nâ”‚   â”œâ”€â”€ Hemorrhagic Stroke (ì¶œí˜ˆì„± ë‡Œì¡¸ì¤‘)\nâ”‚   â”‚   â””â”€â”€ ì›ì¸: Trauma, Bleeding d/o (Hemophilia), AVM\nâ”‚   â””â”€â”€ Todd's Paralysis (í† ë“œ ë§ˆë¹„)\nâ”‚       â””â”€â”€ â˜… Diagnosis of Exclusion (ë°°ì œ ì§„ë‹¨)! ì ˆëŒ€ ë¨¼ì € ê°€ì •í•˜ì§€ ë§ ê²ƒ.\nâ”‚\nâ”œâ”€â”€ 2. Intraventricular Hemorrhage (IVH: The Quiet Door)\nâ”‚   â”œâ”€â”€ ëŒ€ìƒ: Premature infants (<32 weeks)\nâ”‚   â”œâ”€â”€ í•´ë¶€í•™ì  ì›ì¸: Germinal Matrix fragility (ì•½í•œ í˜ˆê´€)\nâ”‚   â”œâ”€â”€ Screening: Head Ultrasound (Routine for preemies)\nâ”‚   â””â”€â”€ í•©ë³‘ì¦: Hydrocephalus (Communicating)\nâ”‚\nâ”œâ”€â”€ 3. Pediatric Epilepsy Syndromes (Age-Dependent Patterns)\nâ”‚   â”œâ”€â”€ Infantile Spasms (West Syndrome, <1 yr)\nâ”‚   â”‚   â”œâ”€â”€ SX: Jackknife spasms\nâ”‚   â”‚   â”œâ”€â”€ EEG: Hypsarrhythmia\nâ”‚   â”‚   â””â”€â”€ TX: ACTH (Adrenocorticotropic hormone)\nâ”‚   â”œâ”€â”€ Lennox-Gastaut Syndrome (Toddler/Child, 3-5 yrs)\nâ”‚   â”‚   â”œâ”€â”€ SX: Regression, Intellectual disability\nâ”‚   â”‚   â””â”€â”€ EEG: Slow spike-and-wave\nâ”‚   â””â”€â”€ Juvenile Myoclonic Epilepsy (JME, Teenager)\nâ”‚       â”œâ”€â”€ SX: Morning myoclonus (ì–‘ì¹˜ì§ˆí•˜ë‹¤ ì¹«ì†” ë˜ì§)\nâ”‚       â”œâ”€â”€ Trigger: Alcohol, Sleep deprivation\nâ”‚       â””â”€â”€ TX: Valproic Acid\nâ”‚\nâ””â”€â”€ 4. Febrile Seizures (ì—´ì„± ê²½ë ¨)\n    â”œâ”€â”€ Simple Febrile Seizure (ë‹¨ìˆœ)\n    â”‚   â””â”€â”€ <15min, Generalized, 1x/24hr â†’ Reassurance\n    â””â”€â”€ Complex Febrile Seizure (ë³µí•©)\n        â””â”€â”€ >15min, Focal, >1x/24hr â†’ Workup needed`\n---\n### **VERIFICATION (0:00 ~ 0:30)**\n> \"I want you to picture two different doors in a pediatric emergency department. Behind door number one, the energy is just frantic. You have a parent rushing in, they're carrying a three-year-old, the kid was totally fine just playing with blocks, and then boom, their right arm and leg just went completely dead weight, limp. It looks like a stroke. It acts like a stroke. Exactly. But your brain kind of hesitates because, well, it's a toddler.\"\n>\n---\n## **Part 1: Acute Hemiplegia & Stroke in Children (Door #1)** ğŸšªğŸƒâ€â™‚ï¸ğŸ’¨\n### **1. The Clinical Scenario (Vignette Anchor)**\n- **ìƒí™©:** 3ì„¸ ì•„ì´ê°€ ë¸”ë¡ ë†€ì´ë¥¼ í•˜ë‹¤ê°€ ê°‘ìê¸° ì˜¤ë¥¸ìª½ íŒ”ë‹¤ë¦¬ì— í˜ì´ ë¹ ì§€ë©´ì„œ ì¶• ëŠ˜ì–´ì§ (Dead weight/Limp).\n- **ë¶€ëª¨ ë°˜ì‘:** íŒ¨ë‹‰ ìƒíƒœë¡œ ì‘ê¸‰ì‹¤ë¡œ ë›°ì–´ ë“¤ì–´ì˜´.\n- **ì˜ì‚¬ì˜ ë”œë ˆë§ˆ:** \"ì„¤ë§ˆ ì• í•œí…Œ ë‡Œì¡¸ì¤‘(Stroke)ì´?\"ë¼ê³  ìƒê°í•˜ë©° ì£¼ì €í•˜ê²Œ ë¨.\n### **2. Differential Diagnosis Table: Why do kids get strokes?**\nì–´ë¥¸ë“¤ì˜ ë‡Œì¡¸ì¤‘(ì£½ìƒê²½í™”ì¦, í¡ì—° ë“±)ê³¼ëŠ” ì›ì¸ì´ ì™„ì „íˆ ë‹¤ë¦…ë‹ˆë‹¤! ğŸ™…â€â™‚ï¸\n| **Type** | **Key Etiologies (ì›ì¸)** | **ë¹„ê³ ** |\n| --- | --- | --- |\n| **Ischemic Stroke** (í—ˆí˜ˆì„±) | â€¢ **Cardiac Disease:** ì„ ì²œì„± ì‹¬ì¥ ê¸°í˜• (Patent Foramen Ovale ë“±)\nâ€¢ **Hematologic:** **Sickle Cell Disease** (SCD, ë§¤ìš° ì¤‘ìš”!), Prothrombotic disorders | êµ¬ì¡°ì (Structural) ë¬¸ì œë‚˜ í˜ˆì•¡í•™ì  ë¬¸ì œê°€ ë©”ì¸! |\n| **Hemorrhagic Stroke** (ì¶œí˜ˆì„±) | â€¢ **Trauma:** ì†Œì•„ì—ì„œ ê°€ì¥ í° ì›ì¸ ì¤‘ í•˜ë‚˜\nâ€¢ **Bleeding Disorders:** Hemophilia (í˜ˆìš°ë³‘), Vitamin K deficiency\nâ€¢ **Vascular:** AVM (ë™ì •ë§¥ê¸°í˜•) | ë„˜ì–´ì ¸ì„œ ë¨¸ë¦¬ë¥¼ ë¶€ë”ªíˆê±°ë‚˜, í˜ˆì•¡ ì‘ê³  ì¥ì• ê°€ ìˆëŠ” ê²½ìš°. |\n| Toddâ€™s Paralysis (ë°œì‘ í›„ í•œìª½ ë§ˆë¹„) | ì•„ë˜ ì°¸ê³  |  |\n| Hemiplegic Migraine |   â€¢ ì²­ì†Œë…„ê¸°ì—ì„œ í¸ë‘í†µê³¼ ê´€ë ¨ëœ í˜ë¹ ì§\n  â€¢ Familiy history. ì—„ë§ˆì—ì„œë„ ê°™ì€ ë¬¸ì œ  |  |\n### **3. The Trap: Todd's Paralysis (í† ë“œ ë§ˆë¹„) âš ï¸**\n- **ì •ì˜:** ë°œì‘(Seizure) í›„ ì¼ì‹œì ìœ¼ë¡œ í•œìª½ ë§ˆë¹„(Hemiparesis)ê°€ ì˜¤ëŠ” í˜„ìƒ.\n- **íŠ¹ì§•:**\n    - Self-resolving (ì €ì ˆë¡œ ì¢‹ì•„ì§).\n    - ë³´í†µ ëª‡ ì‹œê°„ ë‚´ì— íšŒë³µë¨.\n    - ë°œì‘ í›„ í˜¼ë€ ìƒíƒœ(Post-ictal confusion/groggy) ë™ë°˜.\n- **â˜… WARNING (Board Trap):** \"Todd's Paralysis\"ëŠ” **ë°°ì œ ì§„ë‹¨(Diagnosis of Exclusion)**ì…ë‹ˆë‹¤!\n    - ì ˆëŒ€ë¡œ \"ì•„, ë°©ê¸ˆ ë°œì‘í–ˆìœ¼ë‹ˆê¹Œ ë§ˆë¹„ëŠ” ê·¸ëƒ¥ Todd's Paralysisê² ì§€? ê¸°ë‹¤ë ¤ë³´ì.\"ë¼ê³  ë‹¨ì • ì§€ìœ¼ë©´ ì•ˆ ë©ë‹ˆë‹¤. âŒ\n    - **Gold Standard:** ë°˜ë“œì‹œ Strokeì„ ë¨¼ì € ë°°ì œí•´ì•¼ í•¨.\n### **4. Workup & Management** ğŸ¥\n- **Next Best Step (Diagnosis):** **MRI of the Brain + MRA (Magnetic Resonance Angiography)** â˜…\n    - ì¼ë°˜ MRIë¡œëŠ” ë¶€ì¡±í•©ë‹ˆë‹¤. ì†Œì•„ ë‡Œì¡¸ì¤‘ì€ í˜ˆê´€ ê¸°í˜•(Vascular anomaly)ì´ë‚˜ ë§‰í˜(Occlusion)ì„ í™•ì¸í•´ì•¼ í•˜ë¯€ë¡œ **MRA(í˜ˆê´€ ì¡°ì˜)**ê°€ í•„ìˆ˜ì…ë‹ˆë‹¤. Urgentí•˜ê²Œ ì‹œí–‰í•´ì•¼ í•©ë‹ˆë‹¤.\n---\n## **Part 2: Intraventricular Hemorrhage (IVH) (Door #2)** ğŸšªğŸ¤«ğŸ‘¶\n###","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-251"}
{"chunk_type":"transcript_chunk","text":"### **2. Pathophysiology: The Plumping Problem** ğŸ©¸\n- **ëŒ€ìƒ:** **Premature Infants (ë¯¸ìˆ™ì•„)**, íŠ¹íˆ **32ì£¼ ë¯¸ë§Œ** ì¶œìƒì•„.\n- **í•µì‹¬ êµ¬ì¡°ë¬¼:** **Germinal Matrix (ë°°ì•„ê¸°ì§ˆ)**\n    - ë‡Œì‹¤(Ventricle) ê·¼ì²˜ì— ìœ„ì¹˜í•˜ë©°, ìƒˆë¡œìš´ ë‡Œì„¸í¬ê°€ ë§Œë“¤ì–´ì§€ëŠ” ê³³.\n    - ì´ê³³ì˜ í˜ˆê´€ì€ ë§ˆì¹˜ **\"ì –ì€ íœ´ì§€(Wet tissue paper)\"**ì²˜ëŸ¼ ë§¤ìš° ì•½í•©ë‹ˆë‹¤. (Structural supportê°€ ì—†ìŒ).\n- **ê¸°ì „:** ë¯¸ìˆ™ì•„ì˜ í˜ˆì•• ë³€í™”, í˜¸í¡ ê³¤ë€(Respiratory distress) ë“±ìœ¼ë¡œ ì¸í•œ ìŠ¤íŠ¸ë ˆìŠ¤ â†’ ì•½í•œ í˜ˆê´€ì´ í‘ í„°ì§ â†’ ë‡Œì‹¤ ë‚´ ì¶œí˜ˆ(IVH).\n### **3. Diagnosis & Screening** ğŸ–¥ï¸\n- **Clinical Signs:**\n    - ìµœëŒ€ 50%ëŠ” **Clinically Silent (ë¬´ì¦ìƒ)**. ğŸ˜±\n    - ì‹¬í•œ ê²½ìš°: ë¶ˆë£©í•œ ëŒ€ì²œë¬¸(Bulging fontanelle), ë¹ˆí˜ˆ(Anemia), ë¬´í˜¸í¡(Apnea).\n- **Imaging (Gold Standard):** **Cranial Ultrasound (ë‡Œ ì´ˆìŒíŒŒ)** â˜…\n    - CTë¥¼ ì°ì§€ ì•ŠìŠµë‹ˆë‹¤ (ë°©ì‚¬ì„  í”¼í­ ë°©ì§€).\n    - **Protocol:** ëª¨ë“  32ì£¼ ë¯¸ë§Œ ë¯¸ìˆ™ì•„ëŠ” ì¦ìƒì´ ì—†ë”ë¼ë„ **Routine Screening Ultrasound**ë¥¼ ì‹œí–‰í•´ì•¼ í•©ë‹ˆë‹¤. (Must memorize!)\n    - ì´ˆìŒíŒŒì—ì„œ ë‡Œì‹¤ì€ ê·¸ëƒ¥ ê²€ì •ìƒ‰ì´ì—¬ì•¼í•˜ëŠ”ë° í•˜ì–€ìƒ‰ì¸ í”¼ê°€ ë³´ì¸ë‹¤ â˜…\n### **4. Complications**\n- **Post-Hemorrhagic Hydrocephalus:** í”¼ ë–¡(Blood clot)ì´ ë‡Œì²™ìˆ˜ì•¡(CSF) ë°°ì¶œêµ¬(Drain)ë¥¼ ë§‰ìŒ â†’ ë¨¸ë¦¬ê°€ ì»¤ì§€ê³  ë‡Œì•• ìƒìŠ¹.â†’ bulging fontanelle â†’ ì´ˆìŒíŒŒì°ìœ¼ì„¸ìš”.\n- **Management:** ë¨¸ë¦¬ ë‘˜ë ˆ(Head circumference)ë¥¼ ì£¼ê¸°ì ìœ¼ë¡œ ì¸¡ì •. í•„ìš”ì‹œ Shunt ìˆ˜ìˆ .\n---\n## **Part 3: Pediatric Epilepsy Syndromes (The Big Three)** ğŸ“‰ğŸ‘¶ğŸ‘¦ğŸ§‘\në‚˜ì´(Age)ì™€ íŒ¨í„´(Pattern)ì„ ë§¤ì¹­í•˜ëŠ” ê²ƒì´ ì‹œí—˜ì˜ í•µì‹¬ì…ë‹ˆë‹¤!\n### **1. Infantile Spasms (West Syndrome) - Infants (<1 yr) ğŸ‘¶**\n> **ìƒí™©:** ë§¤ìš° ì¡°ìš©í•œ ì‘ê¸‰ì‹¤. ë¶€ëª¨ê°€ 6ê°œì›” ëœ ì•„ê¸°ë¥¼ ì•ˆê³  ì˜´.\n>\n> **ì¦ìƒ:** \"ì„ ìƒë‹˜, ì• ê°€ ìê¾¸ ìœ—ëª¸ì¼ìœ¼í‚¤ê¸°(Sit-ups/Crunches)ë¥¼ í•˜ë ¤ëŠ” ê²ƒ ê°™ì•„ìš”.\"\n>\n> **ì‹¤ì²´:** ê·€ì—¬ì›Œ ë³´ì´ì§€ë§Œ, ì‚¬ì‹¤ì€ **Catastrophic Brain Emergency (ì¬ì•™ì ì¸ ë‡Œ ì‘ê¸‰ ìƒí™©)**ì¼ ìˆ˜ ìˆìŒ. ì´ê²ƒì€ ë°œë‹¬ ê°€ëŠ¥ì„±ì„ ì˜êµ¬ì ìœ¼ë¡œ íŒŒê´´í•  ìˆ˜ ìˆëŠ” ë¬´ì„œìš´ ìƒí™©ì…ë‹ˆë‹¤.\n>\n- **Key Feature:** **Jackknife Spasms** (ì­ë‚˜ì´í”„ì²˜ëŸ¼ ëª¸ì„ ì ‘ìŒ). (ë¶€ëª¨ë“¤ì´ ê·¸ëƒ¥ ë¬´ì‹œí•˜ê¸° ì‰¬ì›€. colicì´ë‚˜ ê·¸ëƒ¥ ê·€ì—¬ì›Œë³´ì´ëŠ” í–‰ë™..ì¸ì¤„..)\n- **EEG Finding:** **Hypsarrhythmia (ê³ ì£¼íŒŒë¶€ì •ë‡ŒíŒŒ)** â˜… - \"Chaotic, High amplitude, Disorganized scribbles.\"\n- **Treatment (Gold Standard):** **ACTH (Adrenocorticotropic Hormone)** â˜…\n    - ì¼ë°˜ì ì¸ í•­ê²½ë ¨ì œê°€ ì•„ë‹™ë‹ˆë‹¤! ìŠ¤í…Œë¡œì´ë“œ í˜¸ë¥´ëª¬ ìš”ë²•ì´ 1ì°¨ ì¹˜ë£Œì œì…ë‹ˆë‹¤.\n- **Prognosis:** ì¹˜ë£Œê°€ ëŠ¦ì–´ì§€ë©´ ì˜êµ¬ì ì¸ ë°œë‹¬ ì§€ì—°(Intellectual Disability) ì´ˆë˜. ì‘ê¸‰ ìƒí™©ì…ë‹ˆë‹¤!\n### **2. Lennox-Gastaut Syndrome - Toddlers/Children (3-5 yrs) ğŸ‘¦**\n- **Context:** ë³´í†µ ì´ì „ì— West Syndromeì„ ì•“ì•˜ë˜ ì•„ì´ê°€ ì§„í–‰ë˜ê±°ë‚˜, ë°œë‹¬ ì§€ì—°ì´ ìˆëŠ” ì•„ì´ì—ê²Œì„œ ë°œìƒ.\n- **Symptoms:**\n    - ì—¬ëŸ¬ ì¢…ë¥˜ì˜ ë°œì‘(Multiple seizure types: Atonic, Tonic, Absence etc.)\n    - **Regression (í‡´í–‰):** ì˜ í•˜ë˜ ë§ì„ ëª» í•˜ê±°ë‚˜ ë°œë‹¬ì´ ë©ˆì¶¤.\n    - Intellectual Disability (ì§€ì  ì¥ì• ) ë™ë°˜.\n- **EEG Finding:** **Slow Spike-and-Wave Pattern (< 2.5 Hz)** â˜…\n- **Takeaway:** ì˜ˆí›„ê°€ ì¢‹ì§€ ì•Šê³  ì¹˜ë£Œê°€ ì–´ë µìŠµë‹ˆë‹¤ (Refractory).\n### **3. Juvenile Myoclonic Epilepsy (JME) - Teenagers ğŸ§‘ğŸ¤**\n- **Vignette:** 10ëŒ€ ì²­ì†Œë…„. í•™êµ ê°€ê¸° ì „ ì•„ì¹¨, ì–‘ì¹˜ì§ˆí•˜ë‹¤ê°€ ì¹«ì†”ì„ ë–¨ì–´ëœ¨ë¦¼(Myoclonic jerk). í˜¹ì€ ì‹œë¦¬ì–¼ ê·¸ë¦‡ì„ ì—ìŒ. \"ë‹¨ìˆœíˆ ë¤ë²™ëŒ€ê±°ë‚˜ í”¼ê³¤í•´ì„œ\"ë¼ê³  ì°©ê°í•˜ê¸° ì‰¬ì›€.\n- **Pattern:** **Morning Myoclonus** (ì•„ì¹¨ì— ë°œìƒí•˜ëŠ” ê·¼ìœ¡ íŠ).\n- **Triggers:**\n    - **Sleep Deprivation (ìˆ˜ë©´ ë¶€ì¡±)**: ì‹œí—˜ ê¸°ê°„ ë°¤ìƒ˜ ê³µë¶€. ğŸ“š\n    - **Alcohol (ìˆ )**: ëŒ€í•™ ì‹ ì…ìƒ í™˜ì˜íšŒ ë‹¤ìŒ ë‚  ì•„ì¹¨ ë°œì‘. ğŸº\n- **EEG Finding:** **4-6 Hz Polyspike and Wave**.\n- **Treatment:** **Valproic Acid (ë°œí”„ë¡œì‚°)** â˜… (Lifelong medicationì¸ ê²½ìš°ê°€ ë§ìŒ).\n---\n## **Part 4: Febrile Seizures (ì—´ì„± ê²½ë ¨)** ğŸŒ¡ï¸ğŸ”¥","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-271"}
{"chunk_type":"transcript_chunk","text":"ë¶€ëª¨ë“¤ì´ ê°€ì¥ ë¬´ì„œì›Œí•˜ì§€ë§Œ, ì˜ì‚¬ëŠ” ê°€ì¥ ì¹¨ì°©í•´ì•¼ í•˜ëŠ” ìƒí™©ì…ë‹ˆë‹¤.\n### **1. Definitions & Classification (Must Memorize Table)**\n| **Feature** | **Simple Febrile Seizure (ë‹¨ìˆœ) âœ…** | **Complex Febrile Seizure (ë³µí•©) âš ï¸** |\n| --- | --- | --- |\n| **Duration (ì§€ì† ì‹œê°„)** | < 15 minutes (ì§§ìŒ) | > 15 minutes (ê¹€) |\n| **Type (í˜•íƒœ)** | Generalized (ì „ì‹  ë°œì‘, ì˜¨ëª¸ì„ ë–ª) | Focal (ë¶€ë¶„ ë°œì‘, í•œìª½ íŒ”ë§Œ ë–ª) |\n| **Frequency (ë¹ˆë„)** | 24ì‹œê°„ ë‚´ 1íšŒ | 24ì‹œê°„ ë‚´ 2íšŒ ì´ìƒ (ë°˜ë³µ) |\n| **Recovery** | ê¸ˆë°© íšŒë³µë¨ (Rapid return to baseline) | íšŒë³µì´ ëŠë¦¬ê±°ë‚˜ Todd's paralysis ë™ë°˜ ê°€ëŠ¥ |\n### **2. Management: The Rules** ğŸ“œ\n- **Simple Febrile Seizure:**\n    - **Action:** **Reassurance (ì•ˆì‹¬ì‹œí‚¤ê¸°)** & Discharge (ê·€ê°€).\n    - NO Imaging (CT/MRI X), NO EEG X.\n    - í•´ì—´ì œ(Antipyretics like Acetaminophen)ëŠ” ì—´ì„ ë‚´ë¦¬ì§€ë§Œ ë°œì‘ ì¬ë°œì„ ë§‰ì§€ëŠ” ëª»í•¨. (ë¶€ëª¨ êµìœ¡ í¬ì¸íŠ¸)\n- **Complex Febrile Seizure:**\n    - **Action:** Workup í•„ìš”. ì…ì› ê³ ë ¤, ë‡ŒíŒŒ(EEG)ë‚˜ MRI ê³ ë ¤ ê°€ëŠ¥. ë­”ê°€ ë‹¤ë¥¸ ì›ì¸ì´ ìˆëŠ”ì§€ ì°¾ì•„ë´ì•¼ í•¨.\n    - LP (r/o meningitis, r/o encephalitis), EEG, Imaging\n    - BZ to abort the seizure\n### **3. The Meningitis Fear (ë‡Œìˆ˜ë§‰ì—¼ ê°ë³„)** ğŸ¦ \n- ì—´ + ê²½ë ¨ = Meningitis?? í•­ìƒ ê³ ë¯¼ë˜ëŠ” ë¶€ë¶„.\n- ì•„ë˜ì— í•´ë‹¹ë˜ë©´ LPë¥¼ í•˜ê³  antibioticsê³ ë ¤í•œë‹¤.\n- **Lumbar Puncture (LP, ë‡Œì²™ìˆ˜ì•¡ ê²€ì‚¬) Indications:**\n    - PE sign: Meningeal Signs (ëª© ë»£ë»£í•¨, Kernig/Brudzinski sign), bulging fontanelle\n    - **Altered Mental Status (ì˜ì‹ ë³€í™”):** ë°œì‘ í›„ ê¸ˆë°© ê¹¨ì§€ ì•Šê³  ê³„ì† ì²˜ì ¸ ìˆì„ ë•Œ (>10-15ë¶„ ì´ìƒ). post ictal confusionì´ ê¸¸ë‹¤.\n    - **Unvaccinated (ë°±ì‹  ë¯¸ì ‘ì¢…):** Hib, Pneumococcal ë°±ì‹ ì„ ì•ˆ ë§ì€ ê²½ìš° (ì„¸ê· ì„± ë‡Œìˆ˜ë§‰ì—¼ ìœ„í—˜ â†‘)\n    - Petechial rash\n    - **Antibiotics use:** ì´ë¯¸ í•­ìƒì œë¥¼ ì“°ê³  ìˆì–´ì„œ ì¦ìƒì´ ê°€ë ¤ì§„ ê²½ìš° (Masked symptoms).\n---\n## **RAPID FIRE RECAP: Scenario Testing** ğŸ”«ğŸ”¥\në§ˆì§€ë§‰ìœ¼ë¡œ ë°°ìš´ ë‚´ìš©ì„ ì‹œë‚˜ë¦¬ì˜¤ë¡œ ì •ë¦¬í•´ ë´…ì‹œë‹¤! (Audio Recap Section)\n| **Scenario** | **Diagnosis** | **Key Management/Next Step** |\n| --- | --- | --- |\n| **#1** 6ê°œì›” ì˜ì•„, Jackknife spasms (ëª¸ì„ ì ‘ìŒ) | **Infantile Spasms (West Syndrome)** | **Tx: ACTH** (Start ASAP to save brain!) |\n| **#2** 10ëŒ€ ì²­ì†Œë…„, ì•„ì¹¨ì— ì¹«ì†”ì„ ë–¨ì–´ëœ¨ë¦¼ (Morning jerks) | **Juvenile Myoclonic Epilepsy (JME)** | **Tx: Valproic Acid** (Look for sleep/alcohol triggers) |\n| **#3** 3ì„¸ ìœ ì•„, ë°œì‘ í›„ ì™¼ìª½ íŒ”ë‹¤ë¦¬ê°€ ì¶• ëŠ˜ì–´ì§ (Limp) | **Potential Stroke** (Todd's ParalysisëŠ” ë°°ì œ ì§„ë‹¨!) | **Dx: MRI Brain + MRA** (Urgent!)\nì–´ë¦°ì• ë“¤ì€ í˜ˆë¥˜ë¬¸ì œ í™•ì¸í•˜ê¸° ìœ„í•´ì„œ ì˜ìƒ ê²€ì‚¬í•œë‹¤. (Todd ì˜ì‹¬ë˜ì–´ë„) |\n| **#4** 30ì£¼ ë¯¸ìˆ™ì•„, ì‹ ìƒì•„ì‹¤(NICU) ì…ì› ì¤‘ (ì¦ìƒ ì—†ìŒ) | **IVH Risk** (Germinal Matrix Bleed) | **Screening: Head Ultrasound** at <32 weeks |\n| **#5** 3ì„¸, ì—´ë‚˜ê³  5ë¶„ê°„ ì „ì‹  ê²½ë ¨, ê¸ˆë°© ê¹¨ì–´ë‚¨ | **Simple Febrile Seizure** | **Tx: Discharge with Reassurance** (ì§‘ì— ê°€ì„¸ìš” ğŸ‘‹) |\n---\n### **Confidence Level & Key Caveats**\n- **Confidence Score:** 1.0 (Audio content fully captured and structured)\n- **Key Caveats:**\n    - ì˜¤ë””ì˜¤ì—ì„œëŠ” 32ì£¼ ë¯¸ë§Œì„ IVH ìŠ¤í¬ë¦¬ë‹ ê¸°ì¤€ìœ¼ë¡œ ì œì‹œí–ˆì§€ë§Œ, ì‹¤ì œ ì„ìƒ ê°€ì´ë“œë¼ì¸ì€ ê¸°ê´€ë§ˆë‹¤ ì•½ê°„ ë‹¤ë¥¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤ (ë³´í†µ <30-32ì£¼).\n    - Todd's ParalysisëŠ” ì ˆëŒ€ \"ì¶”ì •\"í•˜ì§€ ë§ê³  Strokeë¥¼ ë¨¼ì € R/O(ë°°ì œ) í•´ì•¼ í•œë‹¤ëŠ” ì ì´ ê°€ì¥ ì¤‘ìš”í•©ë‹ˆë‹¤.\n    - ì†Œì•„ Strokeì˜ ì›ì¸ ì¤‘ Sickle Cell DiseaseëŠ” í•œêµ­ì¸ì—ê²Œ ë“œë¬¼ì§€ë§Œ USMLEì—ì„œëŠ” ë§¤ìš° ì¤‘ìš”í•œ Key factorì…ë‹ˆë‹¤.\n# ğŸ¥ USMLE Step 2 CK Deep Dive: Critical Care, Environmental & Anesthesia ğŸš€\n### ğŸ“‹ Overview (TL;DR)ã…‹\nì˜¤ëŠ˜ì˜ Deep DiveëŠ” **Critical Care Neurology(ì¤‘í™˜ì ì‹ ê²½í•™)**, **Environmental Injuries(í™˜ê²½ ì‘ê¸‰)**, ê·¸ë¦¬ê³  **Anesthesia Complications(ë§ˆì·¨ í•©ë³‘ì¦)**ì„ ë‹¤ë£¹ë‹ˆë‹¤. USMLEì—ì„œ ì‚¬ë‘í•˜ëŠ” \"High-Stakes\" ì£¼ì œë“¤ë¡œ, ìƒëª…ì„ ìœ„í˜‘í•˜ëŠ” ìƒí™©ì—ì„œì˜ **Rapid Decision Making**ì´ í•µì‹¬ì…ë‹ˆë‹¤.\n- **Neuro Critical Care:** Sympathetic Storming (PSH), Brain Death Criteria, PICS.\n- **Environmental:** Heat Stroke (Classic vs. Exertional), Hypothermia Management.\n- **Anesthesia:** Malignant Hyperthermia, Epidural Complications, Succinylcholine Risks.\n---","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-291"}
{"chunk_type":"transcript_chunk","text":"### ğŸ§ Verification (0:00 ~ 0:30)\n> \"Welcome back to the deep dive. Today we're... putting on the white coats. We're shifting gears from our usual thing to some really high stakes preparation.\"\n> \n> \n> \"That's right. So for the next 20 minutes or so, think of us as your expert medical tutors, we're not just podcasters. And you, listening, you're the student getting ready for the USMLE Step 2 CK.\"\n> \n> \"Yep. And the mission today is all about building a robust clinical mental framework. We're hitting critical care neurology...\"\n>\n---\n### ğŸŒ³ Meta-Cognitive Top-Down Classification\nì˜í•™ì  ë§¥ë½ì„ êµ¬ì¡°í™”í•˜ê¸° ìœ„í•œ ê³„ì¸µí˜• íŠ¸ë¦¬ì…ë‹ˆë‹¤. ì˜¤ëŠ˜ì˜ ì£¼ì œê°€ ì–´ë””ì— ìœ„ì¹˜í•˜ëŠ”ì§€ í™•ì¸í•˜ì„¸ìš”!\nPlaintext\n`CRITICAL CARE & EMERGENCY MEDICINE\nâ”‚\nâ”œâ”€â”€ ğŸ§  Neuro Critical Care\nâ”‚   â”œâ”€â”€ Hyperactive State\nâ”‚   â”‚   â””â”€â”€ Paroxysmal Sympathetic Hyperactivity (PSH) \"Storming\"\nâ”‚   â”œâ”€â”€ Loss of Function\nâ”‚   â”‚   â”œâ”€â”€ Brain Death (Irreversible)\nâ”‚   â”‚   â””â”€â”€ Coma (Potentially Reversible)\nâ”‚   â””â”€â”€ Chronic Sequelae\nâ”‚       â””â”€â”€ Post-Intensive Care Syndrome (PICS)\nâ”‚\nâ”œâ”€â”€ ğŸŒ¡ï¸ Environmental Injuries (Thermoregulation Failure)\nâ”‚   â”œâ”€â”€ Hyperthermia (Heat)\nâ”‚   â”‚   â”œâ”€â”€ Heat Exhaustion (CNS Intact)\nâ”‚   â”‚   â””â”€â”€ Heat Stroke (CNS Dysfunction)\nâ”‚   â”‚       â”œâ”€â”€ Classic (Non-exertional, Elderly)\nâ”‚   â”‚       â””â”€â”€ Exertional (Athletes)\nâ”‚   â””â”€â”€ Hypothermia (Cold)\nâ”‚       â”œâ”€â”€ Mild (Shivering)\nâ”‚       â”œâ”€â”€ Moderate (No shivering)\nâ”‚       â””â”€â”€ Severe (Coma/Arrhythmia)\nâ”‚\nâ””â”€â”€ ğŸ’‰ Anesthesia Complications\n    â”œâ”€â”€ Hypermetabolic Crisis\n    â”‚   â””â”€â”€ Malignant Hyperthermia (MH)\n    â”œâ”€â”€ Neuraxial Complications\n    â”‚   â”œâ”€â”€ Post-dural Puncture Headache\n    â”‚   â””â”€â”€ High Spinal (Resp. Paralysis)\n    â””â”€â”€ Drug Specific\n        â””â”€â”€ Succinylcholine Induced Hyperkalemia`\n---\n# 1. Neuro Critical Care: The \"Storm\" & The \"Silence\" ğŸ§ âš¡ï¸\n### ğŸšª Doorway Thought: Clinical Vignette\në‘ ëª…ì˜ í™˜ìê°€ ìˆìŠµë‹ˆë‹¤. ë‘˜ ë‹¤ **Autonomic Explosion** ìƒíƒœì²˜ëŸ¼ ë³´ì…ë‹ˆë‹¤.\n1. **Patient A (ICU):** ì‹¬ê°í•œ TBI(Traumatic Brain Injury) í›„ íšŒë³µ ì¤‘. ê°„í˜¸ì‚¬ê°€ ë‹¨ìˆœíˆ ìŠ¤í€ì§€ ëª©ìš•(Sponge bath)ì„ ì‹œí‚¤ëŠ”ë° ê°‘ìê¸° ì‹¬ë°•ìˆ˜ ê¸‰ì¦, í˜ˆì•• ìƒìŠ¹, ê³ ì—´, ì‹ì€ë•€ì´ ë¹„ ì˜¤ë“¯ ìŸì•„ì§.\n2. **Patient B (OR):** ìˆ˜ìˆ ì„ ìœ„í•´ ë§‰ ì‚½ê´€(Intubation)í•¨. ê°‘ìê¸° í„± ê·¼ìœ¡(Jaw muscle)ì´ ëŒì²˜ëŸ¼ êµ³ê³ (Clamped shut), í™˜ê¸°(Ventilation)ê°€ ì˜ ë˜ëŠ”ë°ë„ í˜¸ê¸°ë§ ì´ì‚°í™”íƒ„ì†Œ(ETCO2)ê°€ ë¯¸ì¹œ ë“¯ì´ ì¹˜ì†ŸìŒ.\nğŸ‘‰ **Diagnosis?**\n- Patient A: **Paroxysmal Sympathetic Hyperactivity (PSH)** a.k.a \"Storming\"\n- Patient B: **Malignant Hyperthermia (MH)**\n---\n## 1-1. Paroxysmal Sympathetic Hyperactivity (PSH)\n- **Concept:** TBI ë“±ìœ¼ë¡œ ì¸í•´ Cortical inhibition(ëŒ€ë‡Œì˜ ì œì–´)ì´ ëŠì–´ì§„ ìƒíƒœ. Brainstem(ë‡Œê°„)ì˜ Fight or Flight ì„¼í„°ê°€ ë¸Œë ˆì´í¬ ì—†ì´ í­ì£¼í•˜ëŠ” ê²ƒ.\n- **Trigger:** í†µì¦ì´ ì—†ëŠ” ìê·¹(Non-painful stimuli)ì´ íŠ¸ë¦¬ê±°ê°€ ë¨.\n    - ì˜ˆ: ëª©ìš•(Bathing), ì²´ìœ„ ë³€ê²½(Turning), ê°€ë˜ í¡ì…(Suctioning).\n- **Signs (Cluster of 5):**\n    1. Tachycardia (ë¹ˆë§¥)\n    2. Hypertension (ê³ í˜ˆì••)\n    3. Tachypnea (ë¹ˆí˜¸í¡)\n    4. Fever (ê³ ì—´)\n    5. Diaphoresis (ë°œí•œ)\n    - *Note:* 20~30ë¶„ ì •ë„ ì§€ì†ë¨. ë‹¨ìˆœí•œ ê³µí¬ ë°˜ì‘(Scare)ì´ ì•„ë‹˜.\n### ğŸ’Š Management\ní™”í•™ì  ì¥ë²½(Chemical Barrier)ì„ ë‹¤ì‹œ ì„¸ì›Œì¤˜ì•¼ í•©ë‹ˆë‹¤.\n- **Goal:** Replace the inhibition.\n- **Medications:**\n    - **Opioids:** í†µì¦ ì¡°ì ˆ ë° ì§„ì •.\n    - **GABA Agonists:** **Baclofen** (ì–µì œì„± ì‹ í˜¸ ê°•í™”).\n    - **Alpha-2 Agonists:** **Clonidine**, **Dexmedetomidine** (êµê°ì‹ ê²½ ìœ ì¶œ ì°¨ë‹¨).","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-311"}
{"chunk_type":"transcript_chunk","text":"---\n## 1-2. Post-Intensive Care Syndrome (PICS) ğŸ“‰\nICU ìƒì¡´ì˜ ëŒ€ê°€(Price of survival). í‡´ì› í›„ baselineìœ¼ë¡œ ëŒì•„ê°€ì§€ ëª»í•˜ëŠ” í˜„ìƒ.\n- **The 3 Domains (Rule of 50s - 50% ì´ìƒì˜ ìƒì¡´ìê°€ ê²ªìŒ):**\n    1. **Psychiatric:** Major Depression, PTSD.\n    2. **Neurocognitive:** Dementia-like deficits (ê¸°ì–µë ¥, ì§‘ì¤‘ë ¥ ì €í•˜, ì‹¤í–‰ ê¸°ëŠ¥ ì¥ì• ). ì›ì¸ì€ CNS hypoxia, neuro-inflammation ë“±.\n    3. **Physical:** \"ICU Acquired Weakness\" (ê·¼ìœ¡ ìœ„ì¶•, ê±°ë™ ëŠ¥ë ¥ ìƒì‹¤).\n### ğŸ›¡ï¸ Prevention: ICU Liberation Strategies (Gold Standard) â˜…\nê¸°ì°¨(PICS Train)ê°€ ì˜¤ëŠ” ê²ƒì„ ë§‰ì•„ì•¼ í•©ë‹ˆë‹¤.\n- **Physical:** **Early PT/Mobilization** (ì•ˆì „í•˜ìë§ˆì ë°”ë¡œ ì›€ì§ì´ê²Œ í•¨).\n- **Pharmacological:** Deliriumì„ ìœ ë°œí•˜ëŠ” ì•½ë¬¼ ìµœì†Œí™”.\n- **Protocol:**\n    - **SAT (Spontaneous Awakening Trial):** ë§¤ì¼ ì§„ì •ì œë¥¼ êº¼ì„œ ê¹¨ì›Œë´„.\n    - **SBT (Spontaneous Breathing Trial):** ë§¤ì¼ ìë°œ í˜¸í¡ ëŠ¥ë ¥ì„ í…ŒìŠ¤íŠ¸í•¨.\n    - ë‡Œë¥¼ ê³„ì† \"Engage\" ì‹œí‚¤ëŠ” ê²ƒì´ í•µì‹¬!\n---\n# 2. Brain Death: The Final Diagnosis ğŸ’€\n**Brain Death vs. Cardiac Death:**\n- Cardiac Death: ì‹¬ì¥ì´ ë©ˆì¶¤.\n- Brain Death: ë‡Œê°„(Brainstem)ê¹Œì§€ ì™„ì „íˆ ê¸°ëŠ¥ ì •ì§€. ì‹¬ì¥ì€ ì¸ê³µí˜¸í¡ê¸° ë•ë¶„ì— ëœ€.\n### ğŸ›‘ Prerequisites (Before you confirm)\ní™˜ìì—ê²Œ ì†ì„ ëŒ€ê¸° ì „ì— í™•ì¸í•´ì•¼ í•  ê²ƒë“¤:\n1. **Known Irreversible Cause:** (ì˜ˆ: Massive TBI, Anoxic injury). ë¯¸ìŠ¤í„°ë¦¬ í™˜ìì—ê²Œ ë‡Œì‚¬ ì„ ì–¸ ë¶ˆê°€.\n2. **Body Capable of Response:**\n    - Temp > 36Â°C (ì €ì²´ì˜¨ì¦ ë°°ì œ).\n    - SBP > 100 mmHg (ì‡¼í¬ ìƒíƒœ ë°°ì œ).\n    - No Electrolyte/Metabolic issues.\n    - No Paralytics/Sedatives on board.\n### ğŸ”¨ The Exam (Brainstem Reflexes)\nTop-to-Bottomìœ¼ë¡œ ë‡Œê°„ ë°˜ì‚¬ê°€ **ëª¨ë‘ ì†Œì‹¤(Absent)**ë˜ì–´ì•¼ í•¨.\n- Pupils: Fixed & Dilated (Non-reactive).\n- Corneal Reflex: Absent.\n- Oculo-vestibular (Cold Caloric/Doll's eyes): Absent.\n- Gag/Cough: Absent.\n- **Motor Response:** **No Brain-originating motor response.**\n    - âš ï¸ **HUGE TRAP:** **Spinal Reflexes** (Deep tendon reflex, ë¬´ë¦ ì¹˜ë©´ ë°˜ì‘í•˜ëŠ” ê²ƒ)ëŠ” ë‚¨ì•„ìˆì„ ìˆ˜ ìˆìŒ! ë‡Œê°€ ê´€ì—¬í•˜ì§€ ì•ŠëŠ” ì²™ìˆ˜ ë°˜ì‚¬ì´ê¸° ë•Œë¬¸. í™˜ìì˜ ì†ì„ ë§Œì¡ŒëŠ”ë° ì›€ì°”í•œë‹¤ê³  í•´ì„œ ë‡Œì‚¬ê°€ ì•„ë‹ˆë¼ê³  íŒë‹¨í•˜ë©´ ì•ˆ ë¨(Lazarus sign ë“±).\n### ğŸŒ¬ï¸ The Apnea Test (The Definitive Test / Gold Standard) â˜…\nê°€ì¥ ì›ì´ˆì ì¸ ë‡Œê°„ ê¸°ëŠ¥ì¸ \"í˜¸í¡ ë“œë¼ì´ë¸Œ(Drive to breathe)\"ë¥¼ í…ŒìŠ¤íŠ¸í•¨.\n1. **Pre-oxygenate:** ì‚°ì†Œë¥¼ ì¶©ë¶„íˆ ì¤Œ.\n2. **Disconnect Ventilator:** í˜¸í¡ê¸°ë¥¼ ë—Œ.\n3. **Wait:** 8~10ë¶„ ê´€ì°°.\n4. **Positive Criteria (Brain Death Confirmed):**\n    - **No Respiratory Effort** (ê°€ìŠ´ ì›€ì§ì„ ì—†ìŒ).\n    - **PaCO2 > 60 mmHg** (í˜¹ì€ ë² ì´ìŠ¤ë¼ì¸ë³´ë‹¤ 20 ì´ìƒ ìƒìŠ¹).\n    - **pH < 7.28** (Acidosis).\n- *Note:* í™˜ìê°€ ë¶ˆì•ˆì •í•´ì„œ Apnea testë¥¼ ëª»í•˜ë©´? **Ancillary Tests** (EEG Flatline, Cerebral Angiography - No flow) ì‚¬ìš©.","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-331"}
{"chunk_type":"transcript_chunk","text":"### â¤ï¸ Organ Donation Physiology\në‡Œì‚¬ í›„ ì‹ ì²´ëŠ” ë¶•ê´´(Collapse)í•˜ê¸° ì‹œì‘í•¨. ì¥ê¸° ê¸°ì¦ì„ ìœ„í•´ ê¸°ëŠ¥ì„ ìœ ì§€í•´ì•¼ í•¨.\n1. **Diabetes Insipidus (DI):** ë‡Œí•˜ìˆ˜ì²´ í›„ì—½ ì‚¬ë§ â†’ ADH ì•ˆ ë‚˜ì˜´ â†’ ì†Œë³€ í­ë°œ(ì‹œê°„ë‹¹ 1Lì”©).\n    - ğŸ‘‰ **Tx:** Desmopressin, Massive Fluids.\n2. **Systemic Hypotension:** êµê°ì‹ ê²½ í†¤ ìƒì‹¤ â†’ í˜ˆê´€ í™•ì¥.\n    - ğŸ‘‰ **Tx:** Pressors, Fluids.\n3. **Hypothermia:** ì‹œìƒí•˜ë¶€(Thermostat) ì‚¬ë§. \n    - ğŸ‘‰ **Tx:** Warming blankets (Active external warming).\n---\n# 3. Environmental Injuries: Heat & Cold ğŸŒ¡ï¸\n## 3-1. Heat Stroke vs. Heat Exhaustion ğŸ”¥\nê¸°ì¤€ì : **Core Temp 40Â°C (104Â°F)** + **CNS Dysfunction (Mental Status)**\n| **Feature** | **Heat Exhaustion** | **Heat Stroke (Emergency!)** |\n| --- | --- | --- |\n| **Temperature** | < 40Â°C | **> 40Â°C** |\n| **CNS Status** | **Normal** (ì§œì¦ë‚¼ ìˆœ ìˆì–´ë„ í˜¼ëˆì€ ì—†ìŒ) | **Confused, Seizure, Coma** |\n| **Treatment** | Fluids, Cool environment | **Rapid Cooling** (See below) |\n### â„ï¸ Heat Stroke Types & Management (High Yield!)\në‘ ê°€ì§€ íƒ€ì…ì˜ ì¹˜ë£Œë²•ì´ ë‹¤ë¥´ë‹¤ëŠ” ê²ƒì´ ì‹œí—˜ í¬ì¸íŠ¸!\n1. **Classic (Non-exertional):**\n    - **Who:** í• ë¨¸ë‹ˆ(Elderly), í•­ì½œë¦°ì„± ì•½ë¬¼ ë³µìš©ì(ë•€ ì•ˆ ë‚¨).\n    - **Skin:** **Dry** & Hot.\n    - **Tx:** **Evaporative Cooling** (ë¯¸ì§€ê·¼í•œ ë¬¼ ë¿Œë¦¬ê³  ì„ í’ê¸° í‹€ê¸°).\n        - âš ï¸ **Warning:** **Ice Water Immersion ê¸ˆì§€!** ë…¸ì¸ì€ ì°¬ë¬¼ì— ë“¤ì–´ê°€ë©´ í˜ˆê´€ ìˆ˜ì¶•(Vasoconstriction)ìœ¼ë¡œ ì—´ì„ ê°€ë‘ê³ , ì˜¤í•œ(Shivering)ìœ¼ë¡œ ì—´ì„ ë” ìƒì‚°í•˜ì—¬ ì‚¬ë§ë¥ ì´ ì˜¬ë¼ê°.\n2. **Exertional:**\n    - Heat exhaustionê³¼ Exertional heat strokeê³¼ì˜ ì°¨ì´ì :\n        - *ì˜ì‹ì´ ì†Œì‹¤ë˜ì–´ìˆê³ , ì²´ì˜¨ì´ 40ë„ ì´ìƒì„.*\n    - **Who:** ìš´ë™ì„ ìˆ˜, êµ°ì¸, ìœ¡ì²´ë…¸ë™ì.\n    - **Skin:** **Sweating** profusley (ëŒ€ì‚¬ì„± ì—´ ìƒì‚°).\n    - **Tx:** **Ice Water Immersion** (ì–¼ìŒë¬¼ì— ë‹´ê·¸ê¸°). ì Šê³  ê±´ê°•í•´ì„œ ì „ë„(Conduction) ëƒ‰ê°ì´ ê°€ì¥ ë¹ ë¥´ê³  íš¨ê³¼ì .\n## 3-2. Hypothermia ğŸ¥¶\n- **Mild (32-35Â°C):** ì˜¤í•œ(Shivering) ìˆìŒ.\n    - ğŸ‘‰ **Tx:** **Passive External Rewarming** (ë‹´ìš” ë®ê¸°, ì –ì€ ì˜· ì œê±°).\n- **Moderate (28-32Â°C):** ì˜¤í•œ ë©ˆì¶¤(ì—ë„ˆì§€ ê³ ê°ˆ), ê¸°ë©´(Lethargic).\n    - ğŸ‘‰ **Tx:** **Active External Rewarming** (ì˜¨ì—´ íŒ¨ë“œ, ë”°ëœ»í•œ ëª©ìš•).\n- **Severe (<28Â°C):** í˜¼ìˆ˜(Coma), ì‹¬ì‹¤ì„¸ë™(V-fib) ìœ„í—˜.\n    - ğŸ‘‰ **Tx:** **Active Internal Rewarming** (Warm IV fluids, Warm Lavage - Bladder/Peritoneal, ECMO). \"Core\"ë¶€í„° ë°ì›Œì•¼ í•¨.\n    - ì €ì²´ì˜¨ì¦ bradycardiaì—ì„œëŠ” atropineë“±ì´ íš¨ê³¼ê°€ ì—†ìŒ. (pacemakerê°€ ì–¼ì–´ìˆìŒ.)\n    â†’ ì•½ ëŒ€ì‹  ì²´ì˜¨ì„ ë¨¼ì € ì˜¬ë ¤ì¤˜ì•¼í•¨.\n- Frostbite:\n    - pallor skin, anesthesia, blistering, necrosis\n    - Management:\n        - water bath\n        - rewarming\n        - **Refreezing Risk:** ë™ìƒ(Frostbite) ë¶€ìœ„ê°€ ë‹¤ì‹œ ì–¼ ê°€ëŠ¥ì„±ì´ ìˆë‹¤ë©´ ì ˆëŒ€ ë…¹ì´ì§€ ë§ˆë¼(Thaw). ì¡°ì§ ê´´ì‚¬ê°€ í›¨ì”¬ ì‹¬í•´ì§. â˜…\n---\n# 4. Anesthesia Complications ğŸ˜·\n## 4-1. Malignant Hyperthermia (MH) ğŸ”¥\n- **Genetic:** Ryanodine Receptor ë³€ì´ (Autosomal Dominant).\n- **Trigger:** **Volatile Anesthetics** (Halothane, Sevoflurane ë“±) + **Succinylcholine**.\n- **Pathophysiology:** ê·¼ìœ¡ ì„¸í¬ ë‚´ ì¹¼ìŠ˜(Ca2+) í†µì œ ë¶ˆëŠ¥ â†’ ê·¼ìœ¡ ìˆ˜ì¶• ì§€ì† â†’ ëŒ€ì‚¬ í­ë°œ.\n- **Signs:**\n    - **Early:** Masseter Muscle Rigidity (í„± ê·¼ìœ¡ ê°•ì§), **Rising ETCO2** (í™˜ê¸° ì˜ ë˜ëŠ”ë°ë„ CO2 ìƒìŠ¹ - ì´ì‚°í™”íƒ„ì†ŒëŠ” ëŒ€ì‚¬ ì‚°ë¬¼ì„).\n    - **Late:** Hyperthermia (ì—´ì€ ë‚˜ì¤‘ì— ë‚¨), Rhabdomyolysis, Hyperkalemia.\n- **Tx (Gold Standard):** â˜…\n    1. **Stop Trigger** immediately.\n    2. **Dantrolene** IV (RyR antagonist - ê·¼ìœ¡ ì´ì™„).\n## 4-2. Succinylcholine Risks â˜ ï¸\n- **Mechanism:** Depolarizing blocker. ìˆ˜ìš©ì²´ì— ë¶™ì–´ì„œ íƒˆë¶„ê·¹(Depolarization)ì„ ì‹œí‚´. ì´ ê³¼ì •ì—ì„œ ì„¸í¬ ë‚´ **K+ (ì¹¼ë¥¨)**ì´ ë°–ìœ¼ë¡œ ì¡°ê¸ˆ ë‚˜ì˜´.\n- **Contraindications:** **Upregulation of ACh Receptors**ê°€ ìˆëŠ” í™˜ìë“¤.\n    - Burn victims (í™”ìƒ), Crush injury, Stroke/Denervation, Guillain-Barre.\n    - ì´ í™˜ìë“¤ì€ ê·¼ìœ¡ ì „ì²´ì— ìˆ˜ìš©ì²´ê°€ ê¹”ë ¤ìˆì–´ì„œ Suxë¥¼ ì“°ë©´ K+ê°€ ëŒ€ëŸ‰ ë°©ì¶œë¨ â†’ **Cardiac Arrest**.\n    - ğŸ‘‰ **Next Best Step:** **Rocuronium** or **Vecuronium** (Non-depolarizing) ì‚¬ìš©.","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-351"}
{"chunk_type":"transcript_chunk","text":"## 4-3. Neuraxial Anesthesia (Epidural/Spinal)\n- **Hypotension:** êµê°ì‹ ê²½ ì°¨ë‹¨(Sympathetic blockade) â†’ í˜ˆê´€ í™•ì¥. (m/c complication).\n- **High Spinal:** ë§ˆì·¨ì œê°€ ë„ˆë¬´ ë†’ê²Œ ì˜¬ë¼ê°€ì„œ C3-C5(íš¡ê²©ë§‰) ë§ˆë¹„ â†’ Respiratory Arrest. (ìƒì§€ì˜ í˜ì´ ì•½í•´ì§€ë©´ ì˜ì‹¬..)\n- **Post-dural Puncture Headache:** ë°”ëŠ˜ì´ Duraë¥¼ ëš«ìŒ â†’ CSF ëˆ„ì¶œ.\n    - íŠ¹ì§•: ì„œ ìˆìœ¼ë©´(Upright) ì•„í”„ê³  ëˆ„ìš°ë©´(Supine) ì¢‹ì•„ì§.\n    - ğŸ‘‰ **Tx:** **Epidural Blood Patch** (ë³¸ì¸ í”¼ë¥¼ ì£¼ì…í•´ì„œ êµ¬ë©ì„ ë§‰ìŒ).\n---\n### ğŸ”¥ Rapid Fire Recap (Summary Table)\n| **Condition** | **Key Trigger/Sign** | **Gold Standard / Next Best Step â˜…** |\n| --- | --- | --- |\n| **PSH (Storming)** | TBI + Non-painful trigger (Bath) | **Opioids, Baclofen, Clonidine** (Replace inhibition) |\n| **Malignant Hyperthermia** | Volatiles/Sux + Jaw Rigidity + â†‘ETCO2 | **Stop Agent + Dantrolene** |\n| **Brain Death** | Absent Reflexes + Apnea | **Apnea Test** (PaCO2 > 60, No breath) |\n| **Classic Heat Stroke** | Grandma, Dry skin, >40Â°C | **Evaporative Cooling** (Mist + Fan) *NO ICE BATH* |\n| **Exertional Heat Stroke** | Athlete, Sweating, >40Â°C | **Ice Water Immersion** |\n| **Hypothermia (Severe)** | < 28Â°C, Coma/Arrhythmia | **Active Internal Rewarming** (Lavage/ECMO) |\n| **PDPH (Headache)** | Better when lying flat | **Epidural Blood Patch** |","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-371"}
{"chunk_type":"recap_quiz_seed","text":"### 4. RAPID FIRE RECAP: Key Associations ğŸ”¥\n- **Ascending Weakness + Diarrhea hx + CSF high protein normal WBC** â†’  **GBS** (Campylobacter). â†’ ìŠ¤í…Œë¡œì´ë“œ ì•ˆì¤Œ â˜… ! IVIG + plasmaphresis\n- **Ascending Weakness + Camping/Hiking + CSF normal + no fever** â†’  **Tick Paralysis** (Look for the tick!).\n- **Chronic GBS (>8 weeks)** â†’  **CIDP** (Give Steroids).\n- **Atrophy + Hyperreflexia (Mixed)** â†’  **ALS**.\n- **Diabetic with Hyperreflexia** â†’  **Spinal Cord Compression** (MRI Spine).\n- **Facial Droop + Forehead Wrinkles SPARED** â†’  **Stroke**.\n- **Facial Droop + Can't wrinkle forehead** â†’  **Bell's Palsy â†’ eye protection**\n- Facial Droop + Hiker â†’ r/o Lyme â†’ Doxycycline\n- Pronator drift â†’ UMN lesion (í”¼ìê°€ ì—ì–´ì§)\n### 5. SYNTHESIZE & REFLECT\n- **Confidence Score:** 1.0 (Confident).\n- **Caveats:** Audio specifically emphasizes avoiding steroids in GBS but using them in CIDP. Don't mix this up! Also, the distinction between \"Sparing the forehead\" (Central/Stroke) and \"Involving the forehead\" (Peripheral/Bell's) is the most common pimping question in neurology rotation. Memorize the wiring diagram!\n---\n**Next Step for User:** Would you like me to create a detailed **Question Bank (Q-Bank)** style quiz based on these specific clinical vignettes to test your retention?\n**VERIFICATION (0:00 ~ 0:30)**\n\"Welcome back to the deep dive. Today we are, uh, shifting gears. We're not just browsing articles; we are basically doing rounds. We're gonna tackle a really high stakes, high stress topic that is, I mean, absolute gold for the USMLE Step 2 CK. We're talking CNS infections. That's right. And this isn't just a casual chat. Think of this as a high intensity one-on-one tutoring session.\"\n---\n### ğŸ“‹ Overview (TL;DR)","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-61"}
{"chunk_type":"recap_quiz_seed","text":"### ğŸ”¥ Rapid Fire Recap (Summary Table)\n| **Condition** | **Key Feature / Vignette** | **Diagnosis (Gold Standard)** | **Treatment / Mgmt** | **Key Caveat âš ï¸** |\n| --- | --- | --- | --- | --- |\n| **PML** | HIV (CD4 < 200), clumsiness\nAsymmetric white lesion with **Non â˜… -enhancing** lesion | MRI Brain -> CSF JC Virus PCR | HAART (Restore immunity) | No specific antiviral. |\n| **Bacterial Meningitis** | Stiff neck, Photophobia, CSF: **Neutrophils**, **Low Glucose** | LP (CSF Analysis)\nHigh neutrophil, low glucose <40,\nhigh protein >250 | Vanc + Ceftriaxone (+ Ampicillin if >50y) + Steroids | CT before LP if **FAILS** signs present. |\n| **Viral Meningitis** | Similar sx but milder, CSF: **Normal Glucose** | LP (CSF Analysis) | Supportive Care (HSV -> Acyclovir) | Lymphocytes predominant. |\n| **TB Meningitis** | Subacute, CSF: **Very Low Glucose**, High Protein | LP | RIPE Therapy + Steroids | Base of brain enhancement often seen. |\n| **Brain Abscess** | Headache, Focal deficit, **Ring-enhancing** lesion | MRI Brain | **Surgical Drainage** + Abx | **NEVER perform LP** (Herniation risk). |\n| **Spinal Epidural Abscess** | IVDU, **Focal Back Pain**, Fever | **MRI Spine** (w/ contrast) | **Urgent Surgery** + Abx | **NEVER perform LP** (Infection spread). |\n---\n**Confidence Score:** 1.0 (Confident)\n**Key Caveats:**\n- ì´ ê°•ì˜ ë…¸íŠ¸ëŠ” USMLE Step 2 CK ìˆ˜í—˜ìš©ìœ¼ë¡œ ìµœì í™”ë˜ì–´ ìˆìŠµë‹ˆë‹¤. ì‹¤ì œ ì„ìƒì—ì„œëŠ” ë¡œì»¬ ê°€ì´ë“œë¼ì¸ì„ ë”°ë¥´ì„¸ìš”.\n- \"Ring-enhancing\" ë³‘ë³€ì€ Abscess ì™¸ì—ë„ Tumor (Metastasis, Glioblastoma), Toxoplasmosis ë“±ì´ ìˆì„ ìˆ˜ ìˆìœ¼ë‹ˆ ê°ë³„ì´ í•„ìš”í•©ë‹ˆë‹¤.\n- Steroid íˆ¬ì—¬ ì‹œì (Meningitis)ì€ í•­ìƒì œ íˆ¬ì—¬ **ì „**ì´ ê°€ì¥ ì´ìƒì ì´ë¼ëŠ” ì ì„ ê¼­ ê¸°ì–µí•˜ì„¸ìš”. (ì†Œì•„ê³¼/ë‚´ê³¼ ê³µí†µ).\n### ğŸ“‹ Overview: CNS Tumors (Deep Dive)\n**TL;DR Summary Table**\n| **Tumor Type** | **Key Feature/Buzzword** | **Location** | **Key Management/Fact** |\n| --- | --- | --- | --- |\n| **Meningioma** | Dural tail, psammoma bodies | Extra-axial, attached to dura | Resect if symptomatic. Observe if asymptomatic. |\n| **Metastasis** | Gray-white junction, multiple lesions | Intraparenchymal | Most common brain tumor in adults. Lung is most common primary. |\n| **Prolactinoma** | Galactorrhea, amenorrhea | Sella turcica | **Medical therapy first** (dopamine agonist: bromocriptine or cabergoline). |\n| **Craniopharyngioma** | Calcified, cystic, kids (bimodal) | Suprasellar | \"Motor oil\" cyst fluid. Bimodal age distribution. |\n| **Pinealoma** | Parinaud syndrome (upward gaze palsy) | Pineal gland | Compresses dorsal midbrain / superior colliculus. |\n| **Schwannoma** | Hearing loss, tinnitus | Cerebellopontine angle | Bilateral suggests **NF2**. |\n| **Choroid plexus papilloma** | Hydrocephalus (CSF overproduction) | Ventricles | Resection (\"stop the faucet\"). |","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-109"}
{"chunk_type":"recap_quiz_seed","text":"### ğŸ”¥ Rapid Fire Recap & Next Steps\n**Key Clinical Pearls:**\n- **Physical Exam:** ëˆˆì„ ìœ„ë¡œ ëª» ì³ë‹¤ë³´ê³ (Upward gaze palsy) = ì•„ë˜ë¥¼ ì³ë‹¤ë³´ëŠ” ë¶€ë¦…ëœ¨ëŠ” ëˆˆ ë¹›ì— ë°˜ì‘ ì•ˆ í•˜ë©´(Light-near dissociation)? â†’ **Pinealoma**.\n- **History:** ì•„ì¹¨ì— ë‘í†µì´ ì‹¬í•˜ê³  êµ¬í†  í›„ í˜¸ì „? â†’ **Increased ICP**.\n- **Imaging:** Dural Tail? â†’ **Meningioma**.\n- **Imaging:** Grey-White Junctionì— ì—¬ëŸ¬ ê°œ? â†’ **Metastasis**.\n- **Treatment:** ProlactinomaëŠ” ìˆ˜ìˆ  ë¨¼ì €? (NO!) â†’ **Dopamine Agonist**.\n- **Treatment:** Metastasis Single Lesion? â†’ **Resection**. Multiple? â†’ **Radiation**.\n**Caveats:**\n- **Melanoma:** MRIì—ì„œ ì¶œí˜ˆ(Bleeding) ì†Œê²¬ì´ ë³´ì´ë©´ 1ìˆœìœ„ë¡œ ì˜ì‹¬í•  ê²ƒ.\n- **Eyes:** ì‹œë ¥ ê²€ì‚¬ë¿ë§Œ ì•„ë‹ˆë¼ ì‹œì•¼(Visual field) ê²€ì‚¬ë¥¼ í†µí•´ Sellar massë¥¼ ë†“ì¹˜ì§€ ë§ ê²ƒ.\n- female pt. seizure, dural tail â†’ meningioma\n- no1 primary for mets brain ca â†’ lung ca\n- bilateral vestibular schwannoma â†’ NF2\n- schwanomma hearing loss ì™¸ ë‹¤ë¥¸ ì¦ìƒ..? â†’ facial numbness (CN5), facial palsy (CN7)\n- calcified sellar mass â†’ craniopharyngioma\n**Next Step for User:**\nWould you like me to generate a **USMLE-style vignettes quiz** based on these tumors to test your retention? (e.g., \"A 45-year-old woman with hearing loss...\" scenarios?)\n### ğŸ“‹ Overview: Pediatric Neurology (Congenital & Developmental)\nì•ˆë…•í•˜ì„¸ìš”! ğŸ‘¨â€âš•ï¸ ì˜¤ëŠ˜ì€ **Pediatric Neurology**, ê·¸ì¤‘ì—ì„œë„ ì„ ì²œì„± ì§ˆí™˜ê³¼ ë°œë‹¬ ë¬¸ì œë¥¼ ë‹¤ë£¹ë‹ˆë‹¤. í”¼ë¶€ ì†Œê²¬(Skin)ì´ ë‡Œ(Brain)ì˜ ìƒíƒœë¥¼ ë§í•´ì£¼ëŠ” **Neurocutaneous disorders**ë¶€í„°, ë“±(Spine)ì˜ ë¬¸ì œ, ë¨¸ë¦¬ í¬ê¸°(Head size), ê·¸ë¦¬ê³  ë‡Œì„±ë§ˆë¹„(CP)ê¹Œì§€! **USMLE High-Yield** í¬ì¸íŠ¸ë“¤ì„ ê½‰ê½‰ ì±„ì›Œë“œë¦´ê²Œìš”. ğŸ§","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-175"}
{"chunk_type":"recap_quiz_seed","text":"### âš¡ Rapid Fire Recap (Summary Table)\n| **Condition** | **Key Clinical Feature / Buzzword** | **Pathophysiology / Gene** |\n| --- | --- | --- |\n| **NF1** | CafÃ©-au-lait, Lisch nodules, Neurofibromas | Chr 17, Neurofibromin |\n| **NF2** | **Bilateral Acoustic Neuromas** (Hearing loss) | Chr 22, Merlin |\n| **Tuberous Sclerosis** | **Ash-leaf spots**, Cardiac Rhabdomyoma, Seizures | TSC1/2, mTOR pathway |\n| **Sturge-Weber** | **Port-Wine Stain**, Seizures (Contralateral) | Somatic GNAQ (Not inherited) |\n| **VHL** | Hemangioblastomas (Retina/Cerebellum), RCC | Chr 3, VHL gene |\n| **Cephalohematoma** | Does **NOT** cross sutures | Subperiosteal blood (Risk: Jaundice) |\n| **Subgaleal Hemorrhage** | **Crosses** sutures, Fluctuant | Emissary veins (Risk: Shock/Death) |\n| **Spastic Diplegia** | **Commando Crawl**, Legs > Arms | Prematurity â†’  PVL |\n---\n**Confidence Score:** 1.0 (Confident)\n**Key Caveats:**\n- ì˜¤ë””ì˜¤ ê°•ì˜ëŠ” \"General Rule\"ì„ ë‹¤ë£¹ë‹ˆë‹¤. ì˜ˆì™¸ì ì¸ ì¼€ì´ìŠ¤(Mosaicism in NF, etc.)ëŠ” í•­ìƒ ì¡´ì¬í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n- CPì˜ ì§„ë‹¨ì€ ì„ìƒì (Clinical)ì´ì§€ë§Œ, í™•ì§„ì„ ìœ„í•´ MRIê°€ í•„ìš”í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n- Scalp swelling ì¤‘ Subgaleal hemorrhageëŠ” ì‘ê¸‰ ìƒí™©ì„ì„ ê¼­ ê¸°ì–µí•˜ì„¸ìš”!\n**Overview: Pediatric Acute Neurology Deep Dive**\nì•ˆë…•í•˜ì„¸ìš”! ì˜¤ëŠ˜ì€ ì†Œì•„ ì‘ê¸‰ ì‹ ê²½í•™(Pediatric Acute Neurology)ì— ëŒ€í•´ ì•„ì£¼ ê¹Šì´ ìˆê²Œ íŒŒê³ ë“¤ì–´ ë³´ê² ìŠµë‹ˆë‹¤. ğŸ§ âš¡ï¸ ë¯¸êµ­ ì˜ì‚¬ êµ­ê°€ê³ ì‹œ(USMLE)ë‚˜ ì„ìƒ í˜„ì¥ì—ì„œ ì •ë§ ì¤‘ìš”í•˜ê²Œ ë‹¤ë£¨ëŠ” **Stroke, IVH, ê·¸ë¦¬ê³  ë‹¤ì–‘í•œ Pediatric Epilepsy Syndromes**ë¥¼ ë‚˜ì´ëŒ€ë³„, ìƒí™©ë³„ë¡œ ì™„ë²½í•˜ê²Œ ì •ë¦¬í•´ ë“œë¦´ê²Œìš”.\nì´ ê°•ì˜ëŠ” \"High-Yield Tutoring Session\" ì»¨ì…‰ìœ¼ë¡œ ì§„í–‰ë©ë‹ˆë‹¤. ë†“ì¹˜ëŠ” ë‚´ìš© ì—†ì´ ê½‰ê½‰ ì±„ì› ìœ¼ë‹ˆ ì§‘ì¤‘í•´ ì£¼ì„¸ìš”! ğŸ”¥\n### **Top-down Classification & Structure (ASCII Text Tree)**","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-241"}